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ABSTRACT 
Current methods of cancer therapy and detection still warrant high demand and 
great developments. Utilising the fundamental magnetism of iron oxide 
nanoparticles, it is possible to harness that magnetic power for the development 
of new, influential therapeutic and imaging modalities. In this thesis, a detailed 
look into the use of iron oxide nanoparticles as a material for magnetic 
thermotherapy and bio-imaging will be undertaken. 
Iron oxide nanoparticles are synthesised using a common co-precipitation 
synthesis. Stabilisation was achieved with citrate molecules followed by 
advanced functionalisation of the nanomaterial with gold achieved via reduction 
of Au
3+
 (HAuCl4) to Au
0
 from the citrate ligands. These materials were shown to 
exhibit remarkable intrinsic heating power when under the influence of an 
external alternating current magnetic field. 
Following the potential of iron oxide nanoparticles functionalised with gold for 
magnetic hyperthermia, multimodal imaging and therapeutic probes were studied. 
Iron oxide gold nano were analysed as possible Raman enhancer substrates.  
Finally, iron oxide nanoparticles were synthesised using an organic photoacoustic 
dye as a stabilising ligand to functionalise the magnetic Fe3O4 cores with optical 
properties. This lead to the novel co-precipitation synthesis of indocyanine green 
(ICG) and Flamma®774 covalently attached to Fe3O4 nanoparticles. 
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1 INTRODUCTION 
 
1.1 OPENING REMARKS 
The study of nanoscale materials has undergone a significant boom in recent 
decades. Thanks to developments in technology, it is now easier than ever to 
study, measure and analyse the nanoscale range. Within materials chemistry, 
nanoparticles have rapidly developed in scope and complexity to be potentially 
considered as the next big breakthrough in science.  
With this in mind, this work will be discussing the research involved in the 
developments of iron oxide nanoparticles for their applications as materials in 
biomedicine. The thesis will start with a detailed understanding of iron oxide 
nanoparticles; from the synthetic beginnings to the current downstream 
technologies. This research here will investigate the synthetic routes of iron oxide 
formation and enhancement of these nanomaterials for targeted applications 
through nanoparticle functionalisation. 
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1.2 NANOSCALE 
Nanoparticles; as a relatively new form in materials chemistry, they have seen 
continuous interest in recent decades. This is due to fascinating and surprising 
properties accessible through their narrow size range. Nanoparticles are defined 
by IUPAC (International Union of Pure and Applied Chemistry)
[1]
 as having at 
least one aerodynamic dimension between 1  – 100 nm resulting in possible 
structures such as; nanospheres, tubes, stars, rods, and sheets. Their small 
dimensions result in a larger surface area per unit volume and a higher proportion 
of surface atoms to bulk. This increases reactivity due to greater numbers of free 
coordination sites and unsaturated bonds. 
The high degree of reactivity means that small changes in the morphology and 
composition of nanoparticles can result in large variations in physicochemical 
properties from both related nanoparticle and bulk materials. A common example 
of this are the optical properties of gold nanoparticles. Nano-sized gold exhibits 
surface plasmon resonance (SPR) bands in the ultraviolet and visible light 
wavelengths which vary depending of the size of the nanoparticles.
[2]
  
Due to the high reactivity of nanoparticles, they can be fundamentally unstable. 
Ligands are therefore utilised to stabilise this surface instability and, complement 
or modify properties. The effect of these variations is therefore fundamental to the 
understanding and development of future nano-devices.
[3,4]
 Ligands are typically 
simply functionalised organic compounds, such as carboxylates, amides and 
phosphonates. This has fuelled research into diverse applications such as 
developing novel materials for biomedicine, technology and catalysis.
[5–8]
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Iron oxide is one material of high interest in the nanoscale range due its intrinsic 
magnetic properties. The utilisation of this magnetism is currently pushing the 
research of iron oxide nanoparticles for novel biomedical devices and treatments. 
 
1.3 IRON OXIDE 
Iron is a highly abundant first row transition metal element that comes in a wide 
variety of forms and readily binds to produce oxides, chlorides, and sulphates. 
Significantly, iron is found within nature as a vital element for life as an electron 
donor and acceptor in the complex oxygen transporter proteins haemoglobin and 
myoglobin. As well as being critical in metallurgy for the advancements in early 
civilisations of the Iron age and in steel alloys today. 
As an element, iron has the chemical structure [Ar]4s
2
3d
6
 and like other transition 
metals can possess a wide range of oxidation states from -2 to +7, with 0, +2, and 
+3 being the most stable. This makes iron a very versatile element.  
Figure 1.1 shows the crystal field stabilisation energy (CFSE) diagrams for Fe(II) 
and Fe(III), in high spin configurations. With a d
6
 orbital configuration, i.e. 6 
electrons in the d-orbitals, Fe(II) will preferentially form octahedral orientations 
due to the inherently smaller splitting as shown by the equation: 
∆𝑡=
4
9
∆𝑜 
     (1.1) 
 The CFSE = -2/5 Δo, for octahedral splitting whereas, for the tetrahedral splitting, 
Δt = -3/5 Δt, or -6/45 Δo. 
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Fe(III) however can occupy both octahedral and tetrahedral sites. As Fe(III) = d
5
 
configuration, when in high spin due to the weak field ligands one lone electron 
occupies each orbital resulting in a net CFSE = 0. Meaning neither octahedral nor 
tetrahedral sites are energetically preferred. 
From the spectrochemical series, weak field ligands – the halides and OH- – 
exhibit a low energy splitting to the d-orbitals. This results in high spin 
configurations being energetically favoured as more energy is required to pair 
repelling electrons than to put them in high spin orbitals. 
Strong field ligands, CN, CO and PPh3, lead to a greater Δo splitting energy 
making the high energy orbitals increasingly inaccessible and low spin complexes 
become more energetically favourable (Figure 1.2). Where the energy require to 
pair the opposite spin electrons is lower than that required to occupy a high spin 
orbital.  
For the iron oxides seen in this thesis, they are coordinated to either Cl
-
 or OH
-
, 
meaning we will typically be dealing with the high spin states of Fe(II) and 
Fe(III). 
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Figure 1.1. Crystal field stabilisation energy (CFSE) of the high spin orbital splitting of 
Fe
2+
 and Fe
3+
. Note that Fe(III) can possess both octahedral and tetrahedral 
sites whereas Fe(II) can only occupy octahedral as it has higher stabilisation 
energy. 
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Figure 1.2. Crystal field stabilisation energy (CFSE) of the low spin orbital splitting of 
octahedral Fe
2+
 and Fe
3+
. Note that both Fe(II) and Fe(III) only possess 
electrons in the ground state (t2g) orbitals due to higher Δo splitting energy. 
 
In this thesis, iron oxides, specifically Fe3O4 and Fe2O3 nanoparticles, are the only 
form of iron considered with iron oxide nanoparticles the major focal point. The 
nanoparticles will be considered as a basis for developments in biomedicine by 
manipulating the intrinsic magnetic properties of the iron atoms within the 
nanostructure. This section will detail the underlying properties of iron oxide and 
its nanoparticle form.  
  
32 
The high levels of development in recent decades are due to the multitude of 
beneficial applications within the biomedical sector and in imaging 
techniques.
[5,6,9]
 These interests arise from the intrinsic magnetic properties that 
iron possesses, and currently range in the development of superparamagnetic iron 
oxide nanoparticles (SPIONs) for:  
• Drug delivery  
• MRI contrast agents  
• Magnetic separation  
• Magnetic hyperthermia 
• Cell separation  
To become applicable for such uses, iron oxide needs to be tailored to have high 
superparamagnetic properties and be suitably stabilised for surface interactions; 
with chemical solvents, biological media, or towards further functionalisation. 
Here we will discuss the modifications (see section 1.3.6) which are common to 
help broaden the scope of these particles through addition of organic or synthetic 
polymers – i.e. dextran, lauric acid, PEG, PVP[10–12] – or metallic and inorganic 
colloids – gold, and silica.[13,14] Surface modification also limits the degree of 
aggregation as without stabilising ligands, iron oxide nanoparticles are 
hydrophobic. Therefore in an aqueous medium the hydrophobic interaction lead to 
aggregation and thus increased effective particles sizes and a reduction in 
paramagnetic properties.
[15]
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1.3.1 FeO 
There are three main compounds of iron oxide that are naturally occurring. 
Iron(II) oxide, FeO, otherwise known as the mineral wüstite is one of those forms 
of iron oxide and makes up to approximately 9% of the Earth’s mantle. It has a 
standard cubic lattice structure in which the Fe(II) and O
2-
 atoms occupy 
octahedral sites. Fe(II) can readily undergo oxidation to Fe(III), making FeO 
thermodynamically unstable under 850
 
K and will decay following the equation: 
4𝐹𝑒𝑂 →  𝐹𝑒 +  𝐹𝑒3𝑂4 
    (1.2) 
 
1.3.2 Fe3O4 
Magnetite, Fe3O4, is one of the main oxides of iron found naturally and has 
received the most interest due its high magnetic potential and its well-known 
biocompatibility in contrast to other transition metal nanoparticles. This 
ferromagnetic property arises from the unpaired electrons present in the high spin 
Fe
3+
 and Fe
2+
 ions  which occupy the interstitial tetrahedral and octahedral sites in 
a face centred cubic (fcc) close packed inverse spinel structure.
[16]
  
This can be shown and written as: 
[𝐴III]𝑇𝑒𝑡[𝐵II𝐴III]𝑂𝑐𝑡𝑋4 = [𝐹𝑒
3+][𝐹𝑒2+𝐹𝑒3+]𝑂4 
(1.3) 
Where A, represents the Fe
3+
 centres and B, the Fe
2+
 centres in Fe3O4.  
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Above a critical temperature, the Curie temperature, Tc, the thermal energy causes 
the magnetic properties of the material to become disordered (See Section 1.5 on 
magnetism). For Fe3O4, Tc = 858 K at which point the ferromagnetism transitions 
to paramagnetism. 
Fe3O4 is not the most thermodynamically stable form and will readily oxidise to 
form γ-Fe2O3. 
 
1.3.3 γ-Fe2O3  
Maghemite, γ-Fe2O3, is the partially oxidised form of Fe3O4 and again is 
superparamagnetic within the nanoscale due to the unpaired electrons present in 
iron. It also exhibits an inverse spinel structure, but vacancies are present within 
the octahedral sites.
[17]
 
In the macroscale, Fe2O3 has a high Néel temperature of ~950 K, compared to 
FeO = 198 K. The Néel temperature is analogous to the Curie temperature, only in 
relation to antiferromagnetic materials and not ferromagnetic. Likewise, it is the 
increased disorder of the magnetic moments trending towards paramagnetism 
within the materials.  
 
1.3.4 Nanoscale iron oxide 
Iron oxide typically exists in two desired forms at the nanoscale range, Fe3O4 and 
γ-Fe2O3, magnetite and maghemite respectively. It has become increasingly 
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common to produce such particles with the possibility to manipulate the size and 
shape to tailor the desired properties.  Both Fe3O4 and γ-Fe2O3 possess magnetic 
moments when particle diameters of < 20 nm are present which are considered to 
be single domain (Figure 1.3), resulting in superparamagnetic iron oxide 
nanoparticles.
[16]
 
 
 
Figure 1.3. Graphic showing the comparison between a) single domain particles and b) 
multi domain particles. 
 
The magnetisation of iron oxide nanoparticles is considered high, although the 
saturation magnetisation (Ms) is typically weaker than that of the bulk mineral. 
Experimental literature values for the Ms of nanoparticles is in the order of 30 – 
80 emu/g with bulk Fe3O4 having Ms in the order of 100 emu/g.
[18]
 
 
a) b) 
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1.3.5 Synthesis 
Iron oxide nanoparticles can be synthesised in a multitude of ways. There are two 
fundamental ways of creating nanoparticles, top down and bottom up. Top down 
involves reducing the size of a macrostructure down to the nanoscale. Bottom up 
is the opposite and involves synthesising nanostructures from their substituents 
into the desired form. 
Here, this chapter will focus on the most common bottom up approaches. With 
each synthetic route having a large effect on a wide range of physical properties of 
the nanoparticles, including; size, shape, degree of polydispersity and surface 
chemistry. 
Methods such as sol-gel syntheses,
[9,19]
 microemulsions,
[20,21]
 hydrothermal 
reactions,
[22]
 and sonochemical reactions
[23]
 are common within literature. 
Within these sol-gel syntheses there are several fundamental mechanisms (Figure 
1.4) Firstly, nucleation of particles, known as LaMer burst nucleation.
[24]
 This 
occurs early in the reaction scheme where there are a high proportion of reactants. 
Generally, the more nucleation points there are, the smaller overall nanoparticles 
can be. These small nucleation points then precipitate out of the solution when the 
saturation point has been reached and act as seeds for further reaction. Then there 
is the growth stage of nanoparticle formation, from small nucleated seeds to 
stabilised nanostructures. This occurs through the thermodynamic process of 
Ostwald ripening. This is where small particles dissolve back into solution and re-
precipitate onto larger ones. This is due to larger particles being more 
energetically favourable because of the reduction in surface area.
[25,26]
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Figure 1.4. Graph showing the three stages of formation of a nanoparticle system from I) 
pre-nucleaction of monomers, II) nucleation of monomers to particle seeds 
and III) growth of the nanoseeds into nanoparticles through Oswald ripening. 
Further aggregation of nanoparticles can occur after growth. 
 
Aggregation of the nanoparticles after the growth stage is also a common problem 
associated with nanoparticle synthesis that researchers are challenged with. A 
cluster of nanoparticles will also affect the surface energy and help to stabilise the 
nanoscale formations. 
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1.3.5.1 Co-precipitation 
Co-precipitation is arguably the most common path for synthesising large scale 
magnetic iron oxide nanoparticles. It is used as a simple, reliable and cheap 
method for highly magnetic nanospheres. Typically achieved when dissolving, 
into aqueous solvent, transition metal salts of varying oxidation number and in the 
correct stoichiometric ratio. Then under an inert atmosphere, addition of a 
reducing agent precipitates the nanoparticles.
[9]
 However, fine control over the 
size distribution is not available due to the kinetic forces at play. 
Co-precipitation of iron oxide is increasingly common in literature. Recent 
developments show Roth et al. synthesising a wide range of nanoparticles (3 – 17 
nm) with a variable degree of magnetisation from 26 – 89 Am2kg-1.[27] 
Furthermore, studies have started to use iron oxide nanoparticles synthesised via 
this route for more clinical applications. . Even more recently, we have seen 
exciting developments in the use of iron oxide nanoparticles, synthesised via a 
modified coprecipitation method, in the extraction of DNA.
[28]
 Utilising 
electrostatic interactions, and surface functionalisation using silica or chitosan, it 
was seen that fast and versatile DNA separation was achievable. This is seen a 
promising avenue of nanobiotechnology, utilising the physiochemical properties 
and magnetism of the iron oxide cores.  
Thomas et al. investigated heating through magnetic hyperthermia and anti-
bacterial properties of iron oxide.
[9]
 Concluding that given stabilising agents 
drastically improve the properties of the nanoparticles, achieving a heating power 
((ILP), see section 1.6.1) of 6.1 x 10
-9
 H
2
kg
-1
, and a total kill of over 10
7
 cfu 
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(colony-forming unit) of the bacteria S. aureus. Very recently similar research 
into chitosan functionalised iron oxide has been investigated into its potential 
antibacterial and antifungal activity.
[29]
 Where here it is proposed that chitosan 
coated Fe3O4 cores could be used as an effective coating material for 
antimicrobial devices. Iron oxide nanoparticles have also been regularly used for 
imaging and MRI agents and current research is still developing such 
nanomaterials.
[30,31]
 
Thermodynamics states that this reaction would precipitate Fe3O4 when a 
stoichiometric ratio 2:1 for Fe
3+
:Fe
2+
 and a pH of 8 – 14.[32] The reduction reaction 
of the ferric and ferrous salts is shown as follows:
[33]
 
𝐹𝑒2+ + 2𝐹𝑒3+ + 8𝑂𝐻−  →  𝐹𝑒3𝑂4 + 4𝐻2𝑂 
   (1.4) 
As mentioned in section 1.3.2, Fe3O4 is not the most thermodynamically stable 
form of iron, therefore readily undergoes oxidation (Figure 1.5) to a less-
favourable product via: 
𝐹𝑒3𝑂4 +  2𝐻
+  →  𝛾-𝐹𝑒2𝑂3 +  𝐹𝑒
2+ +  𝐻2𝑂 
   (1.5) 
Ultimately, iron oxide nanoparticles will finally be oxidised to the unfavourable 
by-product as: 
𝐹𝑒3𝑂4 + 0.25𝑂2 + 4.5𝐻2𝑂 → 3𝐹𝑒(𝑂𝐻)3 
   (1.6) 
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Figure 1.5. Scheme showing the initial surface oxidation of magnetite (Fe3O4) 
nanoparticles to maghemite (Fe2O3) over a given time, t1, and complete 
oxidation of the particle to Fe2O3 after time, t2, when in an oxygen rich 
environment. 
 
Alternatively, another common way of forming highly ordered monodisperse iron 
oxide nanoparticles is via organic solution synthesis, as shown by Park et al.
[34]
 
This typically produces organic soluble iron oxide nanoparticles in high boiling 
point solvents, i.e. 1-octadecene. The disadvantage of this method being that the 
formed nanoparticles are only organically soluble due to the oleate coating, 
meaning that further functionalisation is required to make the iron oxide suitable 
for aqueous systems. This is also a much harsher synthetic procedure requiring 
volatile solvents – including hexane and 1-octadecene – and at very high 
temperatures exceeding 300 
o
C.   
 
1.3.5.2 Hydrothermal 
Hydrothermal synthesis occurs when the reaction is carried out under increased 
temperature and high pressures in an autoclave. Iron (II) chloride (FeCl2.4H2O) is 
dissolved in an aqueous medium at elevated conditions and NH4OH is added as a 
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reducing agent allowing for the oxidation of Fe(II). The advantage of a 
hydrothermal methodology is the independency on an inert atmosphere and reflux 
conditions, resulting in more controllable oxidation of the iron.
[35]
   
In 2009, Ge et al. synthesised Fe3O4 nanoparticles with controllable diameters, 
narrow size distribution, and tuneable magnetic properties. The particles were 
synthesised at 140 
o
C and 2 bar to give diameters in the range of 15-30 nm with 
magnetisation in the range of 53.3-97.4 emu/g.
[36]
 With the ease of tuning the 
nanoparticle magnetisation, hydrothermal synthesis particles are commonly 
developed for MRI. Li et al. have recently demonstrated the facile synthesis of 
targeting MRI probes using a hydrothermal synthesis of iron oxide. Targeting was 
achieved via stabilisation by a polyethyleneimine (PEI) mediated approach and 
fluorescein isothiocyanate (FI) and hyaluronic acid (HA) ligand conjugation. HA-
targeted Fe3O4 NPs are able to be uptaken specifically by specific cancer cells 
overexpressing CD44 antigen receptors.
[37–39]
 
 
1.3.5.3 Micelle 
A micelle, as shown in Figure 1.6, is a supramolecular structure formed of 
surfactant molecules that contain both a hydrophilic ‘head’ and hydrophobic ‘tail’. 
Due to this difference in hydrophilicity, the lipid will aggregate together to form 
an equilibrium between two immiscible solvents, the aqueous and the organic. A 
‘typical’ (oil-in-water) micelle is in aqueous solution, therefore a monolayer of the 
hydrophilic head is in contact with the solvent and a hydrophobic organic centre is 
formed. This forms a nano-droplet within solution and acts as a nano-reactor for 
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any soluble reactants. A reverse micelle is the opposite orientation or in other-
words a reverse of the ratio of aqueous solvent to organic solvent. In this regard, 
micelle reactions give a high degree of control over the size and shape of 
nanoparticles including spheres, cylinders and lamella phases.
[27]
 
 
Figure 1.6. Diagram representing I) a surfactant monomer with a hydrophilic head and 
hydrophobic tail. These monomers for either II) a micelle with an organic 
solvent centre surrounded by aqueous solvent or III) a reverse micelle where 
the aqueous solvent is within the micelle.  
 
For the synthesis of iron oxide nanoparticles in micelles, a water-in-oil emulsion 
is required. The chemistry within the micelles is the same as that of co-
precipitation. The iron salts are water soluble however the micelle limits the 
reaction size resulting in the formation of highly monodisperse nanoparticles. The 
surfactant can be tailored to produce particles of different sizes and morphologies. 
Lee et. al.
[20]
 have achieved the synthesis of gram-amounts of highly crystalline 
monodisperse iron oxide nanoparticles in which they are able to maintain the 
micelle phase.  
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There are difficulties with a reverse micelle reaction, including the formation of 
the micelle solution itself. The ratio of solvents to surfactant has to be precise with 
the surfactant concentration needing to be greater than the critical micelle 
concentration (CMC).  Furthermore, large scale micelle formation of 
nanoparticles is challenging. A large amount of solvent is required for the 
synthesis of a relatively small yield and to maintain the micellular structure during 
the high temperature synthesis.
[20]
 
 
1.3.5.4 Microwave 
Microwave synthesis of iron oxide particles provides requires a closed sealed 
reaction vessel leading to convenient, reliable, and repeatable synthetic 
methodology. Heating is achieved through the dielectric effect giving rise to high 
temperatures at speed making microwave reactions remarkably rapid. Blanco-
Andujar et al. showed how iron oxide nanoparticles coated with citrate can be 
synthesised via microwave assistance. These particles also proved effective for 
magnetic hyperthermia giving a high intrinsic loss parameters of up to 4.2 
nHm
2
kg
-1
.
[40]
 
By dissolving FeCl3.6H2O into a polar solvent (e.g. ethylene glycol) the 
pressurised microwave reactor causes the rapid heating. The reaction can also be 
effectively scaled up as no thermal gradient effects are noted within the solvent 
medium. However, thermal control is difficult leading to ‘hotspots’ with the 
reaction and leading to some drastic morphological changes such as Fe2O3 
nanorings
[41]
 and Fe3O4 nanoroses.
[42]
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Table 1.1: Comparison of the synthetic methods for synthesis of iron oxide nanoparticles 
showing characteristics of each route.
[43]
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Form Table 1.1, it is therefore possible to establish the most suitable reaction 
mechanism, however this is all dependant on the overall properties of the iron 
oxide that are desired. In this research, the co-precipitation reaction was the most 
desirable, giving a narrow size distribution whilst having little synthetic 
complexity and yielding aqueously soluble nanoparticles.  
Thermal decomposition is another widely used synthetic route to highly desirable 
iron oxide nanoparticles. This is the least complex method of forming highly 
monodispersed nanoparticles with finely tuned morphologies. However, the 
particles are often stabilised with an organic surfactant, oleic acid
[34]
, which for 
use in biological systems, requires multiple synthetic steps to achieve ligand 
functionalisation.  
In this thesis, I will mostly explore the potential of the co-precipitation reaction 
for the reasons mentioned above. However, interest is high in the preparation of 
highly monodisperse particles; therefore, you will also see attempts at using this 
method. 
 
1.3.6 Coatings and stabilisation 
One of the most important factors to consider when synthesising nanoparticles is 
the surface coating and stabilisation.
[16,43,44]
 For iron oxide nanoparticles this 
retains the uniform monodisperse nature in both biological and magnetic 
environments preventing aggregation of the colloidal ferrofluid. There requires an 
equilibrium between the attractive and repulsive electrostatic forces, the repulsive 
steric hindrance between individual nanoparticles and, in magnetic nanostructures, 
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the magnetic dipole attractions. To achieve this equilibrium manipulation of 
charged electrostatic forces or the steric repulsion is necessary.  
 
1.3.6.1 Monomeric ligands 
One of the most common stabilising agents developed by Turkevich et al.
[45]
 and 
still in use widely today is citrate ions via the addition of sodium citrate or citric 
acid. The surface of nanoscale iron oxides acts much like a Lewis acid and will 
readily accept a donated electron lone pair. In an aqueous medium this results in 
coordination and hydroxylation of the surface iron ions. Likewise, it has been 
shown that citrate will bind effectively to the surface of magnetite through the 
coordination of one or two of the carboxyl functional groups available. Due to the 
structure of citrate, this leaves an exposed carboxylate group resulting in a surface 
that is negatively charged and hydrophobic. Other monomeric ligands that can 
stabilise iron oxide nanoparticles are sulfates and phosphates as shown by Thomas 
et al.
[9]
 and Sahoo et al.
[46,47]
  
 
1.3.6.2 Organic polymers 
Encapsulation of nanoparticles with polymers is seen as an effective way to 
achieve bio-stability and nontoxicity. Encapsulation can be achieved in situ during 
the growth of the particles or post-synthesis for example the functional PEG 
coated SPION’s for in-vivo MR imaging developed by Lee et al.[48] The most 
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common polymers derivatives seen in literature are polyethylene glycol (PEG), 
chitosan and dextran. 
 
 
Figure 1.7: Chemical structures of the common stabilising polymers polyethylene glycol 
(PEG), dextran and chitosan used for increasing nanoparticle stability and 
biocompatibility. 
 
These polymers are highly flexible and water soluble with well-known 
biocompatibility, and many publications report on the use of encapsulation to 
improve the biocompatibility and retention times of nanoparticles. An important 
factor in the choice of polymers, especially dextran, appears to be the favourable 
size of the chains, up to 40000 Daltons. This can enable optimum polar 
interactions through chelation and hydrogen bonding with iron oxide surfaces. 
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However, encapsulation is generally a physical process, in which there are no 
covalent interactions there is concerns about desorption of the polymer chains and 
break up of structures, i.e. release of the nanoparticles from inside the polymer. 
 
1.3.6.3 Inorganic shells 
Several inorganic materials and metals have been reported to aid in the 
stabilisation and functionality of iron oxide nanoparticles. Silica has been greatly 
exploited for the coating of iron oxide predominantly for its inert qualities and 
high controllability. A silica coating will also reduce aggregation by creating 
shielding of the magnetic dipole attraction. 
As such, Jang et al. have synthesised an iron oxide – silica core shell nanoparticle 
conjugated with a fluorescent dye for use an imaging probe.
[49]
 The single iron 
core of ~13 nm diameter is coated with silica of between 5 – 50 nm thickness. The 
silica, as well as being a stable surface for dye conjugation provided protection to 
fluorescent quenching from the iron oxide core.  
Gold is another inorganic material that has seen recent interest in the coating of 
iron oxide nanoparticles. Like silica, gold is a very inert and biologically stable 
material, making it ideal for the bio-protection of nanoparticles, whilst giving a 
basis for further organic functionalisation. Another benefit for a gold coating is 
the inherent optical properties of gold (see section 1.4). Briefly, gold has long 
been used in biomedical imaging and sensing. To combine and synergise the 
optical advantages of gold with the high intrinsic magnetisation of iron oxide 
nanoparticles is highly desirable. However, given the surface energy of oxides is 
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typically lower than that of a metal, a continuous homogenous coating of gold is 
difficult to achieve. 
There are literature reports for the synthesis of iron oxide – gold nanostructures 
most notably that of Lyon et al. which showed the synthesis of gold coating onto 
iron oxide nanoparticles through iterative hydroxylamine seeding. Fe3O4 was 
synthesised in a co-precipitation method being reduced with NaOH with the 
addition of HAuCl4 and hydroxylamine promoting an Au
3+
 surface catalysed 
reduction, rather than monometallic Au particle nucleation.
[50]
 From personal 
attempts of this method, it becomes evident that the mechanism for the gold 
coating is highly unpredictable and often unreliable. 
In light of the benefits and challenges that arise from inorganic coatings of 
magnetic nanoparticle cores there are several defined morphologies. Firstly there 
are core – shell particles in which an individual iron oxide core is coated wholly 
by the functional coating material.  
Dumbbell or Janus morphologies are seen when one side of the nanostructure 
consists of iron oxide and the alternate side consistent of the functional material, 
such as two individual nanoparticles joined together.  
This has been shown by Yu et al. who demonstrated an Au-Fe3O4 nanostructure 
made up of a 2 – 8 nm magnetic iron oxide particles bound to an individual 5- 20 
nm diameter Au particle. This structure is formed via epitaxial growth of iron 
oxide on the Au seed particles.
[51]
 Xu et al. further developed the dumbbell 
particles as a nanocarrier for therapeutic platin molecules.
[52]
 Again, these 
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mechanisms are highly complex and need to be very specifically formulated to get 
the tailored nanostructures repeatedly and uniformly.  
 
1.4 GOLD 
The precious metal, gold, as well as being highly sought after in its macroscale is 
also a valuable material when looking into nanoscale properties. The section will 
discuss the benefits of gold, and specifically optical and chemical properties.  
Gold has been known to be used in its nanoscale form for millennia. Earliest 
examples are of decorative red coloured glass, such as the 4
th
 century roman 
Lycurgus Cup. This ornate vessel has colloidal gold and silver within the glass 
material forming a dichroic effect. An effect which causes the glass to display and 
undergo a colour change when in varying lighting conditions. When lit from the 
front, a green colour is seen, but from behind, a red colour is displayed due to the 
difference in wavelength absorption of the nanoparticles. Similarly, gold 
nanoparticles have been used in stained glass windows and cranberry glass which 
forms a distinctive red or pink colour.  
In the 1850’s Michael Faraday was the first to synthesize a pure sample of 
colloidal gold and study the optical properties, coming to the conclusion that 
small gold nanoparticles were causing the refraction of different wavelengths of 
light, also known as the Tyndall effect.  
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Figure 1.8. Photo showing the Tyndall effect, in which the light beam passes through the 
pure solution (left) and is refracted due to the presence of nanoparticles in the 
colloidal suspension (right) thus making the beam of light visible
[53]
 
 
Likewise, gold has been used in medicine for generations. First seen in text by 
Pliny the Elder (AD 23-79), he describes the properties and formulation of gold 
remedies. Later, In the Middle Ages, alchemists used gold as a curative treatment 
for various different diseases through drinkable gold – ‘Aurum potabile’ – and as 
a youth tonic.  
In more modern times, technology has advanced leading to greater detail and 
comprehensive studies on gold nanoparticles in medicine. The optical surface 
plasmon resonance effect (SPR) properties of gold nanoparticles are key for the 
development of medical applications. SPR is the diffraction of an incident wave 
caused by the excitation of the surface plasma waves in a metal.
[54,55]
 At optical 
wavelengths, this is found in gold and silver. It is therefore ideal for measuring the 
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refractive index of very thin layers of mater on a metallic surface, including bio-
markers and antibodies in chemical sensors.
[56]
 
Gold nanoparticles have also been utilised by MSOT and photoacoustic imaging 
due to these strong and highly tunable absorption bands.
[57,58]
 There are a wide 
range of morphologies that are achievable through the synthesis of gold 
nanostructures; all with a highly specific absorption wavelengths from anywhere 
between 520 – 2000 nm. Including nanospheres, nanorods, nanostars, and 
nanoprisms.
[59–62]
 This wavelength variation is critical for the nanoparticle NIR 
absorption in the wavelength range of the ‘biological window’ (650–1100 nm), 
where the least amount of biological attenuation occurs.
[63]
 
Furthermore, the optical properties of gold can be used for therapeutic means in 
photodynamic therapy (PDT). Where red light (600 – 700 nm) is theorised to 
excite a photosensitizer which, through an energy transfer, excites ground state 
triplet oxygen into excited singlet oxygen (
1
O2) radicals. If uptake in a malignant 
tumour is great enough, the singlet 
1
O2 will react with and chemically destroy the 
cells. Hone et al.
[64]
 reported that phthalocyanine stabilised nanoparticles can be 
used as a safe reliable photosensitiser and Srivatsan et al.
[65]
 further enhanced the 
efficiency of PDT by using a gold nanocage to act as both a photosensitizer and 
for photosensitizer drug delivery. 
The reactivity of gold is highly significant to its wide use in these biomedical 
applications, most notably, the affinity of sulfur to metallic gold.
[66]
 This is well 
observed in the surface functionalisation of gold nanostructures with thiolated 
polymers, commonly thiol functionalised poly(ethylene) glycol (PEG-SH)
[67,68]
. 
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The thiol functional group provides facile and effective coordination to the metal 
core whilst the polymer, as with FeO surface functionalisation (Section 1.3.6), can 
have inherent properties, such as targeting moieties and high bio-compatibility 
and bio-stability.
[69]
  
 
1.4.1 Synthesis 
The simplest and most common synthetic route to gold nanoparticle synthesis is 
that pioneered by Turkevich et al. in 1951.
[70]
 Aqueous gold ions (Au
3+
, from 
chloroauric acid (HAuCl4)) are reduced to metallic gold (Au
0
) via the addition of 
a reducing agent, sodium citrate. Au
0
 atoms will act as nucleation points for the 
further reduction of Au
3+
 thus forming nanoparticles, which are then stabilised 
from aggregation and excessive growth through capping from the citrate ligands.  
This forms the characteristic ruby red colour of gold colloid solution with the 
particles of good monodispersity and having a mean diameter in the range of 5-20 
nm. To vary this diameter alteration can be made to the percentages of reagents 
used but above 50 nm the citrate stabilisation is ineffective and polydispersity 
arises.
[71]
 However, Bastús et al achieved gold particles upwards of 180 nm in 
dimeter using citrate stabilisation following a kinetically controlled seed mediated 
growth.
[72]
  
Another viable synthetic route to gold nanoparticles is through the Brust-Schiffrin 
method.
[73]
 Wherein HAuCl4 undergoes a phase-transfer from aqueous to organic 
solvent (toluene) via a phase-transfer reagent such as tetraoctylammonium 
bromide (TOAB). Reduction of Au
3+
 to Au
0
 is then achieved with a sodium 
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borohydride (NaBH4) reducing agent and reliably produces large quantities of 
relatively monodisperse samples of small nanocrystals (1-6 nm) and facilitates a 
one pot synthesis for thiol functionalised nanoparticles (Au-SR).
[74]
 This can been 
as the chemical equations:  
𝐻𝐴𝑢𝐶𝑙4(𝑎𝑢) + 𝑇𝑂𝐴𝐵(𝑜𝑟𝑔)  → 𝐻𝐴𝑢𝐶𝑙4(𝑜𝑟𝑔) 
   (1.7) 
𝐻𝐴𝑢𝐶𝑙4(𝑜𝑟𝑔) + 𝑅-𝑆𝐻(𝑜𝑟𝑔) +  𝑁𝑎𝐵𝐻4(𝑎𝑞) → 𝐴𝑢-𝑆𝑅(𝑜𝑟𝑔) 
   (1.8) 
 
 
1.5 MAGNETISM 
Magnetism is a physical phenomenon that has been widely recognised since the 
ancient Greeks, in naturally occurring Fe3O4 (lodestone). It is where materials are 
affected by a magnetic field which arises from the quantum nature of electrons 
within the atoms. An electron has a very small magnetic dipole moment, defined 
as the torque experienced on a vector when subject to an external magnetic field 
which arises from quantum electrodynamics. As a magnetic field is the product of 
a moving electrical current and electrons are charged (-1e, where e is the unit of 
elementary charge (q = 1.60217662 × 10
-19
 coulombs)) a magnetic dipole is 
formed when it spins, thus creating a magnetic field.
[75]
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The magnetic fields are donated by B or H-fields which are closely related and are 
proportional to one another. Where in a vacuum; 
𝑩 = 𝜇0𝑯 
     (1.9) 
With μ0 is the permeability of free space, i.e. the degree of resistance to the 
formation of a magnetic field in a classical vacuum.  
Within a material, the magnetic susceptibility, χm, indicates whether a material 
will be attracted to or repelled from a magnetic field through the equation: 
𝜒𝑚 = 𝜇𝑚 − 1 
     (1.10) 
Where μm is the magnetic permeability of the material. A positive χm results in 
attraction to a magnetic field, such as a paramagnet, whereas a negative value 
leads to repulsion as seen in a diamagnet.  
These magnetic materials follow the Curie law, which states that the magnetic 
susceptibility is inversely proportional to the temperature.  
𝑴 = 𝜒𝑚𝑯 =  
𝐶
𝑇
𝑯 
   (1.11) 
Here, C is the Curie constant, and the resultant magnetism, M, increases when the 
temperature, T, decreases. Alternatively, when T increases the thermal energy 
disrupts the alignment and net magnetisation decreases. This temperature is called 
the Curie temperature (TC). 
When the electron shells of an element or material are full, the individual 
magnetic moments are then cancelled by their opposite electron. Therefore only 
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materials with partially filled orbitals form a net magnetic moment. Magnetism is 
a physical property that is governed by environmental conditions, such as 
temperature and humidity. This section will discuss the multiple forms of 
magnetism, with the most commonly seen being diamagnetism, paramagnetism, 
ferromagnetism, antiferromagnetism and ferrimagnetism.
[76,77]
 
 
1.5.1 Diamagnetism 
Diamagnetism is the most observed form of magnetism, although not the most 
familiar, as it is present in all materials. It arises from paired electrons and induces 
repulsion when applied to a magnetic field. Diamagnets have small magnetic 
susceptibility, and other forms of magnetism will dominate, so only when it is the 
only contribution to the magnetism can a material be classed as a diamagnet. The 
magnetic susceptibility is negative resulting in repulsion from a magnetic field. 
Bismuth is the only naturally occurring diamagnet and superconductors are prime 
examples of perfect diamagents (χm = -1), where given the correct conditions can 
cause total repulsion of the magnetic fields from the inside of the material thus 
causing levitation.
[78,79]
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1.5.2 Paramagnetism 
Paramagnetism occurs from the unpaired electrons within an atom. In a 
paramagnet, the magnetic moments are initially randomly orientated as thermal 
motion is great enough to overcome the weak order of magnetism. Upon the 
introduction of an external magnetic field, the magnetic spins align with the 
applied field forming internally induced magnetic fields (Figure 1.9). This is an 
attractive force between the external field and the induced fields due to the small 
but positive magnetic susceptibility, where χm > 1. When the external magnetic 
field is removed, there is no longer any influence over the internal moments and 
the magnetic properties are not retained. 
 
Figure 1.9. Schematic of a) randomly orientated magnetic moments in a paramagnet 
resulting in zero net magnetisation and b) the alignment of the magnetic 
moments when an external field is applied. B denotes the direction of the 
applied magnetic field. 
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1.5.3 Ferromagnetism 
Ferromagnetism is the strongest and most commonly recognised form of 
magnetism. It is exhibited when a material has a permanent magnetic moment 
from when the individual magnetic moments within the material align forming a 
long range order to the magnet. The parallel magnetic moments are then in a 
preferred lower-energy state and remain the magnetism. 
    
 
Figure 1.10. Schematic showing a) the alignment of the individual magnetic moments in a 
ferromagnetic material and b) The effect of the Curie temperature (TC) on 
randomising the magnetic moments. 
 
The Curie temperature (TC) is the critical temperature at which the intrinsic 
magnetic moments are no longer perfectly aligned (Figure 1.10). This is caused by 
the thermal energy applied being greater than the decrease from the ferromagnetic 
ordering. Some of the most common ferromagnetic atoms are Co, Fe and Ni. 
 
  
59 
1.5.4 Anti-ferromagnetism 
Antiferromagnets occur when the magnetic moments align in an antiparallel 
order. The moments are of equal value therefore there is no net magnetisation in 
the material (Figure 1.11). This occurs bellow the Néel temperature (TN, which is 
synonymous to the Curie temperature, and typically occurs in the order of 10 – 
100 K. 
 
Figure 1.11. A schematic of the magnetic moments present in an antiferromagnet bellow 
the Néel temperature, which results in a net zero magnetic field as the 
opposing spins cancel. 
 
1.5.5 Ferrimagnetism 
Similarly to antiferromagnetism, ferrimagnets have antiparallel magnetic 
moments; however, the opposing spins do not have the same magnitude (Figure 
1.12). This difference in environments results in a net magnetic moment. For a 
ferrimagnet, when the thermal energy is great enough it will overcome the short 
range order of the magnetic moments resulting in randomised magnetic moments 
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and no overall net magnetisation. This is known as the ferrimagnetic Néel 
temperature (TfN). 
 
Figure 1.12. Schematic of the spin alignment present in a ferrimagnet. The opposing spins 
have a lower magnitude resulting in a net magnetic field. 
 
1.5.6 Hysteresis 
Magnetic hysteresis (Figure 1.13) is a phenomenon in which magnetic dipoles in a 
ferromagnet align themselves with an external magnetic field. This demonstrates 
that the magnetisation, M (Am
-1
), is not proportional to the applied field, H. After 
magnetic saturation (M0) is reached, the magnetic dipoles retain a degree of 
magnetisation, known as the remanent saturation, mrs, and therefore do not fully 
relax back to zero. M0 can therefore be seen as a sum of all the magnetic dipoles 
in a material. Applying H in the opposite direction can manipulate the dipoles 
back to zero. The degree of H required to reduce M back to its zero value is 
known as its coercivity, hc.
[76,77]
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Figure 1.13. Graph showing magnetic hysteresis in a ferromagnetic material and the 
effect of an external field. Intensity of the applied magnetic field, 
magnetisation of the material, remanent saturation and coercivity are all 
displayed. 
 
Hysteresis can then be used to categorise different types of magnetic materials; 
between hard and soft magnets. Hard magnets have a wide hysteresis loop, which 
denotes that a large hc is present. This means a larger external field is required to 
neutralise the magnetisation. This has therefore become a key component of 
digital storage
[80]
 whereby soft magnets have a narrow hysteresis and small values 
of hc meaning they can be easily demagnetised.  
In a single-domain particle, due to the magnetic anisotropy, there is time 
dependant relaxation of the two stable antiparallel dipole orientations. Known as 
Néel relaxation (τN), it is the mean time taken for the magnetic dipole vector to 
alternate between these energy minima due to thermal fluctuations and is given by 
the Néel-Arrhenius equation:
[81]
 
Positive Saturation 
Negative Saturation 
hc 
mrs 
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𝜏𝑁 =  𝜏0exp (
𝐾𝑉
𝑘𝐵𝑇
) 
   (1.12) 
Where τN is the attempt time of the material (typically between 10
-9
 – 10-10 s), K is 
the magnetic anisotropy energy density, V is the particle volume, kB is the 
Boltzmann constant and T is temperature. 
 
1.6 BIOMEDICAL APPLICATIONS 
As previously mentioned, iron oxide nanoparticles have great potential as 
biomedical applications. Here, magnetic alternating current hyperthermia 
(MACH) and the medical imaging techniques of multispectral optoacoustic 
tomography (MSOT), magnetic resonance imaging (MRI), and surface enhanced 
Raman scattering (SERS) are the main focus of this study. 
 
1.6.1 Magnetic AC hyperthermia (MACH) 
The process of MACH causes localised heating when magnetic nanoparticles are 
subjected to an alternating magnetic field. This has been proven to be helpful in 
the treatment and necrosis of tumorous cells and bacteria.
[9,82]
 When the SPIONs 
are placed into an AC (alternating current) magnetic field the magnetic moments 
align with the field. As the field alternates it causes the magnetic vector to flip 
which provides energy to the particles and via hysteresis excess energy is 
transferred to heat. This is known as Néel rotation. Brownian rotation, a random 
physical rotation and movement of a particles in solution, also provides some 
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small amount of frictional heating as well.
[83]
  Brown also devised that the Néel 
relaxation will possess randomised Brownian motion about the magnetic 
equilibria. This combination of heating is therefore known as Néel-Brownian 
rotation.
[84,85]
 
 
Figure 1.14. Scheme of Brownian motion, showing the completely randomised motion of 
a nanoparticle as it moves through and interacts/collides with the solute. 
 
Localised heating of 41 – 56 oC can cause damage and ultimately lead to necrosis 
malignant cells at long exposure times.
[86]
 SPIONs can also be used cooperatively 
with chemotherapy drugs for this heating and increases the blood flow to the cells 
which in turn increases the effectiveness of the drugs.
[87,88]
 This ability for the 
nanoparticles to heat is typically recorded via the specific absorption rate (SAR) 
or the intrinsic loss power (ILP).
[89]
 SAR shows the amount of energy absorbed 
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per unit mass when affected by an AC magnetic field and is shown by the 
equation: 
𝑆𝐴𝑅 =  
∆𝑇𝐶
𝑡𝑚𝐹𝑒
 
   (1.13) 
Where ΔT is the change in temperature of the sample, C is the specific heat 
capacity of the material, t is the time over which the AC field is applied and mFe is 
the mass of the iron.
[90,91]
 
This is then related to the IPL via: 
𝐼𝐿𝑃 =
𝑆𝐴𝑅
𝐻2𝑓
 
   (1.14) 
Where H is the power of the alternating magnetic field and f is the frequency of 
said field.
[91]
 This removes the dependence of the field strength and frequency 
from the SAR, which gives an easily comparable value for measuring 
hyperthermia across different systems.
[89]
  
In the literature, previously synthesised commercial magnetic nanoparticles have 
an ILP of 0.15 – 3.1 nHm2kg-1, with Bayer-Schering’s Resovist nanoparticles 
having the greatest ILP. It is also currently the only medically approved ferrofluid 
for use in clinical trials.
[90]
 
Blanco-Andujar et al. has also synthesised citrate stabilised iron oxide 
nanoparticles through microwave synthesis.
[23]
 This produced iron oxide 
nanoparticles with an ILP of up to 4.1 nHm
2
kg
-1
 at a diameter of 17.1 nm.  
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Tiopronin stabilised iron oxide nanoparticles have been synthesised by Thomas et 
al. producing an iron oxide particle with a high ILP of 6.1 nHm2kg-1.
[9]
 These 
nanoparticles were then shown to be powerful antimicrobial solutions. The 
particles themselves showed no antimicrobial activity, only when an alternating 
magnetic field was applied.  
Kossatz et al.
[92]
 has recently synthesised, via aqueous co-precipitation, magnetic 
nanoparticles with an ILP of 8.7 nHm
2
kg
-1
. They then showed good response to 
magnetic hyperthermia in animal tumours studies.  
There have been several detailed reviews and studies into the desired location of 
the SPION’s for the effectiveness of hyperthermia treatments.[82,93,94] Intravenous 
injection of the particles into the blood stream with an external magnetic field can 
manipulate the particles to a desired site. Although, it has been shown that foreign 
iron oxide in the blood stream is quickly removed by the liver. This means a 
longer retention time is required to achieve an effective dosage at the tumour.
[94]
 
Surface functionalisation of the iron oxide nanoparticles with a cancer binding 
drug would also give the particles specificity over where it binds. It is also 
possible for direct intratumoral delivery, which is beneficial to sites which are 
easily accessible and in regions where there is low blood flow such as 
Glioblastoma – a grade IV astrocytoma.[82] Currently there is a clinical patient 
study in Germany, Europe where magnetite nanoparticles are being used in 
conjunction with radiotherapy.
[93]
 
In this thesis will be a discussion towards a way of synthesising and using a gold 
shell coating onto an iron oxide core to help improve stability, functionality and 
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hyperthermia properties (See Chapter 2). It has been shown by Li et al.
[13]
 that 
gold concentrations are important to the morphology of the Fe3O4–Au colloids. 
We now want to see how different morphologies can affect the magnetism and the 
ability of heating via magnetic hyperthermia. 
 
1.6.2 Multispectral optoacoustic tomography (MSOT) 
MSOT is a technique that makes use of photoacoustic properties of a molecule.
[95]
 
Fundamentally, a laser pulse of given wavelength is absorbed by a molecule. This 
molecule then oscillates due to the increased energy and the molecule propagates 
a sounds wave. The frequency and amplitude of the sound waves can then be 
detected via an inducer and provides detailed information about the propagation of 
the sounds waves. This wavelength (λ) and positional (r) dependency produces 
multispectral optoacoustic images, P(r, λ), which gives a non-linear relationship 
with respect to the concentrations of the absorbing molecules. This can be shown 
through the equation: 
𝑃(𝒓, 𝜆) = 𝐶(𝒓)𝛷(𝒓, 𝜆) ∙ ∑ 𝑐𝑖(𝒓)𝜀𝑖(𝜆)
𝑖
 
  (1.15) 
Where C(r) is a scaling factor with respect to the system effects and the 
photoacoustic efficiency (Grüneisen parameter Γ(r)),[96] Φ(r,λ) represents the 
wavelength dependant optical fluence, ci(r) is the associated concentrations at 
position r, and εi(λ) is the wavelength dependent molar extinction coefficients.
[97]
 
Ultimately, due to the Grüneisen parameter, this means that the photoacoustic 
effect is very sensitive to the external environment factors. As such, a change in 
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temperature or pressure can greatly affect the photoacoustic properties of any 
material. 
For the multispectral optoacoustic tomography generation, briefly, a tuneable 
optical parametric oscillator (OPO) pumped by an Nd:YAG laser provides 
excitation pulses with a duration of 9 ns at a repetition rate of 10 Hz with a 
wavelength tuning speed of 10 ms and a peak pulse energy of 100 mJ at 730 nm. 
Ten arms of a fibre bundle provide even illumination of a ring-shaped light strip 
of approx. 8 mm width. PA signals were acquired using a 512-element concave 
transducer array spanning a circular arc of 270°. During MSOT measurements, the 
phantom is translated through the transducer array along its axis to acquire the 
transverse image slices set. 
Due to this, MSOT is rapidly becoming an attractive bio-imaging tool due to the 
ability to generate anatomical images with a deep penetration depth (5-6 cm) 
whilst keeping a high spatiotemporal resolution, all while being a non-radiative 
process.
[98]
 Typically; a short wave near-infrared (NIR) source pulses and 
irradiates the biological tissue and photoacoustic (PA) probe. The NIR pulse is 
absorbed, which generates a small temperature spike resulting in the generation of 
low scattering sound waves via thermoelastic expansion in the tissue medium and 
the probe molecule. Ultrasound transducers detect the incoming acoustic waves 
which can then be processed into ultrasound images.
[99]
 One beneficial property of 
an exogenous PA dye is the ability of spectral unmixing. Endogenous molecules 
such as oxy (HbO2) and deoxy-hemoglobin (Hb), melanin and water all exhibit a 
characteristic photoacoustic spectrum.
[100]
 Because of this, literature studies 
typically use NIR photoacoustic (PA) dyes, with absorption in the region of 700 – 
  
68 
1000 nm. Most commonly used dyes are aromatic organic structures, such as 
indocyanine green (ICG)
[101,102]
, methylene blue, thalocyanine
[103]
, and chlorin 
e6
[104]
. Gold nanomaterials have also been developed to make use of their high 
degree of optical absorbance, such as in gold nanorods. Nanorods are critical 
because the increased length in one dimension gives rise to a higher wavelength of 
absorption than spherical particles of upto 800 nm.
[105]
 
With MSOT, it is then possible to track the dye and analyse specific cellular or 
molecular processes. Therefore a useful tool for the imaging of tissue oxygenation 
and hypoxia, and blood vessel imaging for the likes of vascular disease or 
melanoma.
[106]
 
Photoacoustic imaging is becoming a popular modality in conjunction with other 
modalities to provide complementary information. The advantage of a dual 
modality MSOT-MRI probe is to provide the combination of detailed functional 
and molecular information from MSOT with the very high anatomical resolution 
given by MRI imaging. Kircher et al. have shown the development of a 
multimodal nanoparticle probe capable of MRI-PA-Raman imaging.
[107]
 Using a 
532 nm laser they demonstrate a high photoacoustic efficiency of 2.75 × 10
10
 
cm
−1
M
−1
 from a gold core shell particle coated in a Raman active dye and Gd
3+
 
ions for MRI.  
Furthermore, the use of a series of single molecule Raman-PA probes has been 
shown by Dinish et al.
[58]
 Achieved by incorporating the NIR absorbance required 
for PA imaging into the inherent structure of a cyanine molecule used for Raman 
spectroscopy.  
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1.6.3 Magnetic resonance imaging (MRI) 
MRI is an incredibly useful imaging technique that gives high quality imaging of 
inside the body using the fundamentals of nuclear magnetic resonance (NMR). 
High strength radiofrequency energy is used to excite and detect the relaxation of 
given atomic nuclei when situated inside an electromagnetic field.
[108]
 This gives a 
high spatial resolution and infinite penetration depth which are highly 
advantageous for imaging the contrast in soft tissues. Hydrogen nuclei are the 
most observed, and are abundant in the water and fats of the soft tissues. MRI has 
therefore become a staple in the diagnosis of many different conditions and 
diseases; from various types of cancer tumour screening
[109–111]
 to brain 
functionality, such as the atrophy in Alzheimer’s disease[112] and strokes[113].  
Exogenous contrast agents are typically used to alter the signal generation of the 
endogenous nuclei by decreasing the relaxation times. T2 contrast agents decrease 
the T2 relaxation times and give rise to a strong negative contrast in the image. It 
is the superparamagnetic properties of ultra-small iron oxide nanoparticles give 
rise to a strong T2 spin-spin relaxation contrast,
[114,115]
 whereas, in contrast, 
chelated gadolinium contrast agents proved a strong T1 spin-lattice 
relaxation
[116,117]
. T2 relaxation is typically a faster process than the corresponding 
T1 relaxation. 
T2 relaxation is the time taken after excitation for the magnetic resonance signal to 
decay 1 𝑒⁄ , or 37%, of its original value. This leads to relationship between Mxy, 
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the transverse component of the magnetization vector, and t, the time for which 
the decay occurs, as seen by the equations:
[118]
 
𝑀𝑥𝑦(𝑡) = 𝑀𝑥𝑦(0)𝑒
−𝑡
𝑇2  
   (1.16) 
𝑟2 =  
1
𝑇2 ∙ [𝐶]
 
   (1.17) 
Where r2 (mM
-1
s
-1
) is the relaxivity and is the concentration, [C], dependant 
correlation to the inverse of T2 relaxation times. 
 For examples, literature reports show the r1 and r2 contrasts of various iron oxide 
nanoparticles, each functionalised or synthesised by various routes, differs in 
values.
[119]
 With the highest r2 values seen in literature being within the order of 
>800 mM
-1
s
-1
 for Zn
2+
 doped magnetic nanoparticles.
[120]
 In very recent 
developments, Wei et al. studied ultra-small iron oxide nanoparticles to enhance 
the T1 contrast; making a Gd-free positive contrast agent, with very little chance 
of iron overload in the body.
[121]
 
The combination of multiple nanoscale materials into one functional nanoparticle 
imaging probe has been challenging. Developments from Jin et al. have been able 
to synthesise an iron oxide – gold core – shell nanoconstruct with well-defined 
structural and functional properties. They show that separation of the iron oxide 
and gold layers with a dielectric polymer layer leads to uniform particles with 
good functionality in the NIR range. The combination of magnetic and optical 
properties has therefore enabled a new style of imaging modality in 
magnetomotive photoacoustic (mmPA) imaging.
[122]
 These are critical 
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developments in the developmental use of multimodal imaging techniques 
involving PA and MRI.  
1.6.4 Surface enhanced Raman scattering (SERS) 
Raman scattering, discovered and published in the 1920’s by physicist C. V. 
Raman, is the inelastic scattering of a photon caused by a molecule.
[123]
 The 
incident photon interacts with the molecule, an energy transfer occurs, and a shift 
in the photon wavelength is seen.  
SERS spectroscopy is a surface sensitive technique for the sensing of absorbed 
molecules on a metallic surface which enhances the molecules Raman spectra. 
Enhancement can be up to a factor of 10
15
 making SERS a highly sensitive 
spectroscopic technique able of the detection of minimal quantities of molecules 
and even single molecules.
[124,125]
  
The true mechanism of SERS has yet to be fully understood though experimental 
research and two predominant theories are available. The electromagnetic theory 
states that excitation is caused by localised surface plasmons on the surface of the 
substrate. This can apply to most cases of SERS observed, whereas the chemical 
theory requires a chemical bond between the substrate and analyte to allow a 
surface charge transfer mechanism.  
Most substrates make use of the high optical SPR effects of gold and silver 
nanostructures either as colloidal nanoparticle solutions, nanoparticles grafted to a 
silica (glass) surface, or plasma splutter deposition coatings.
[126–129]
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Being as sensitive as it is, SERS is widely used as a chemical sensor. Detection of 
proteins and antibodies in bioassays is common in industrial laboratories. 
Explosives detection is also important, as low amounts of explosive residue can 
be detected for concealed explosives in terrorism and in old landmines. As such, 
Dasary et al. have reported a highly selective cysteine modified gold nanoparticle 
capable of recognition of 2 picomolar (pM) levels of trinitrotoluene (TNT) in 
aqueous solution.
[130]
 
There is currently great interest in developing highly sensitive and selective SERS 
substrates for chemical sensing. Research is also actively searching for reusable 
and more cost effective materials for SERS such as aluminium and paper 
sensors.
[131–133]
 
 
1.7 THESIS OUTLINE 
This thesis will report on the research undertaken in the synthesis of metallic 
nanoparticles – mostly iron oxide – and their functional applications as 
thermotherapy agents in magnetic hyperthermia and imaging probes in MSOT and 
MRI spectroscopies.  
Chapter 2 starts with the synthesis of iron oxide nanoparticles though the common 
co-precipitation method for their use in magnetic hyperthermia. In an attempt to 
further functionalise the particles, gold was added to the synthetic procedure.   
Chapter 3 will describe the start of a multimodal imaging probe based on an iron 
oxide core. This chapter will show the attempts to making iron oxide 
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nanoparticles SERS active through the functionalisation of the surface with the 
aforementioned gold. Furthermore, gold nanoparticles and nanostars were 
synthesised to show their potential SERS properties. 
Finally, the development of a MSOT-MRI iron oxide nanoparticle probe is 
outlined in Chapter 4. This takes the synthesised iron oxide nanoparticles and the 
covalent attachment of PA dyes to its surface. With these probes in-vivo 
measurements of MSOT and MRI were obtained to demonstrate the effective 
nature of the synthesised nanoparticles. 
This thesis is then completed with a compressive conclusion to the research and a 
proposal for the future direction of this work and any research related to this 
subject matter. 
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2 MAGNETIC HYPERTHERMIA 
 
2.1 INTRODUCTION 
Iron oxide nanoparticles have been known to exhibit significant magnetic heating 
properties when under the influence of an external magnetic field, as described in 
Chapter 1. Within this chapter, the synthesis of iron oxides with various 
stabilising ligands, were explored as to the effects of attempting to use gold as a 
capping agent to enhance functionality.  
As is necessary for nanoparticles, stabilisation of the surface is required. For this, 
the proposal of a gold shell was a promising proposition.  As seen commonly in 
literature, capping agents take multiple forms. From organic polymers,
[18,134,135]
 
inorganic coatings
[136–138]
 and metallic shells. Of these, gold coatings on iron 
oxide nanoparticles have been seen of importance.
[139–142]
 Importantly the addition 
of gold can facilitate the easy covalent binding of ligands and polymers to further 
enhance the nanoparticle usefulness. As is common in chemistry, and biological 
engineering, thiols have a high affinity to metallic gold. It is also proposed that a 
gold coating can be an effective way to limit the surface oxidation and overall 
degradation of the iron oxide nanoparticle. Due to the chemical stability and labile 
reactivity of gold to ambient conditions, a surface coating can protect the 
magnetic core. However to achieve a comprehensive surface coating on the iron 
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oxide surface can be difficult when dealing with such scales and surface 
potentials.
[143]
 Still, even some addition of gold to the iron oxide may be desirable. 
This can present itself as partial encapsulation of a nanoparticle, a dumbbell 
particle, or as an intimately mixed nanocomposite material. The gold can then be 
employed, as mentioned, to improve bio-compatibility and functionality. 
Additionally, gold has a wide range of beneficial optical properties including SPR 
bands, SERS and PA imaging for optical imaging and chemical detection. Gold is 
also a key component in the cancer therapy PDT (photodynamic therapy). The 
combination of magnetic hyperthermia and PDT would then be a multimodal 
attack in the fight against cancer.  
To focus on the therapeutic nature of gold – magnetite/maghemite nanoparticles, 
it is important to consider both materials. Great attention has been given to the 
heating phenomenon when a nanoparticle is placed within an electromagnetic 
field. For iron oxide this involves a rapidly alternating magnetic field (frequency, 
f ≈ 100 kHz to 1.5 MHz) at high field strength (amplitude H > 5 kA/m)  to 
achieve clinical hyperthermia wherein at 40-44
o
C cell apoptosis occurs.
[5]
 
Pathogens and cancer cells are notably more susceptible to this heating, thus make 
more conventional therapies, i.e. chemo/radiotherapy, much more potent. As 
described in Section 1.6, this heat can be quantified by the specific absorption rate 
(SAR/ W/gFeOx) which can then be related to the intrinsic loss parameter (ILP/ 
nHm
2
/kgFeOx). Typically, literature shows that a good quality iron oxide magnetic 
nanoparticle will demonstrate an ILP in the range of 1 - 3 nHm
2
/kgFeOx.
[89,91]
 
In this chapter therefore a discussion and analysis of the effect on the magnetic 
heating properties of iron oxide-gold nanocomposite materials is achieved. Using 
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a novel method, a Turkevich reduction of HAuCl4 was modified to add Au to the 
previously-synthesised citrate capped iron oxide nanoparticles.
[45]
 It was noted 
that the gold did not form core-shell particles or a homogenous capping layer over 
the iron oxide core. However, gold nanoparticles were synthesised amongst the 
iron oxide nanoparticles and the size of the gold nanoparticles grew with positive 
correlation to the amount of HAuCl4 added in the synthetic methodology. The 
iron oxide nanoparticles remained largely unchanged during this post production 
reaction. This lead to the remarkable discovery that the ILP of iron oxide 
increased three fold upon addition of chloroauric acid under optimum conditions.  
 
2.2 MATERIALS & METHODS 
2.2.1 Materials 
All chemicals and were used as received and without further purification. Iron(III) 
chloride hexahydrate (FeCl3.6H2O) (99%), iron(II) chloride tetrahydrate 
(FeCl2.4H2O) (98%), and tetramethylammonium hydroxide (TMAOH) (99%, 
25% w/w water) were purchased from Alfa Aesar.  Ammonium hydroxide 
(NH4OH) (25% in water w/w), citric acid (99%), tiopronin (99%), trisodium 
citrate dihydrate and chloroauric acid (HAuCl4) were all purchased through Sigma 
Aldrich. All water used was distilled to 15 MΩ.  
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2.1.1 Synthesis of tiopronin-stabilised iron oxide nanoparticles 
Fe3O4 nanoparticle co-precipitation requires a 2:1:1 molar ratio of Fe(III): Fe(II): 
surfactant. FeCl3.6H2O (2.703 g, 10 mmol), FeCl2.4H2O (0.995 g, 5 mmol) and 
tiopronin (0.816 g, 5 mmol) were added to degassed H2O (20 mL) under N2. The 
orange solution was heated to 70
o
C and addition of TMAOH (21 mL) was added 
drop wise over 5 minutes, turning the solution black. The solution was allowed to 
cool to room temperature, washed by dialysis (cellulose membrane, M.W. 12 400, 
average flat width 76 mm) for 5 days, and collected with a permanent magnet. A 
black ferrofluid was recovered which was dried at -55
o
C at reduced pressure 
yielding a fine black powder (~ 300 mgmL
-1
). 
 
2.1.2 Synthesis of citrate-stabilised iron oxide nanoparticles 
This co-precipitation synthesis of Fe3O4 is a slightly adjusted method of the 
tiopronin Fe3O4 particles. Similarly; into degassed H2O (80 mL) FeCl3.6H2O 
(4.44 g, 16.4 mmol) and FeCl2.4H2O (1.632 g, 8.2 mmol) were dissolved showing 
an orange solution. The temperature was then raised to 70
o
C under N2 and 
NH4OH (20 mL) was added, turning the solution immediately black, and held for 
30 minutes. Citric acid (4 mL, 0.5 g/mL) was added and the temperature was 
raised to 90
o
C under reflux for 60 minutes. The black solution was cooled to room 
temperature, washed with H2O and collected via a permanent magnet producing a 
fine black powder (~ 250 mgmL
-1
). To obtain these concentrations, the suspension 
was freeze dried under reduced pressure to produce a magnetic black powder 
which was then re-dispersed in H2O (50 mgmL
-1
) with the aid of ultrasonication.  
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2.1.3 Hydrothermal synthesis of oleate-stabilised iron oxide nanoparticles 
To contrast the co-precipitation synthesis mainly used in the this thesis, attempts 
at creating organic soluble iron oxide nanoparticles through the common 
hydrothermal synthesis pioneered by Park et al. were made. Briefly, FeCl3.6H2O 
(2.16 g, 8 mmol) and sodium oleate (7.3 g, ….. mmol) were dissolved in a 
mixture of ethanol (16 mL), hexane (28 mL) and water (12 mL) giving a deep 
orange solution. This was heated to reflux (70
o
C) for 4 hours to form an iron 
oleate intermediate. The products were washed and separated with water (3 x 30 
mL), and the organic solvents were evaporated under reduced pressure leaving a 
red waxy solid.  
For the formation of the nanoparticles from this product, the iron oleate (7.2 g) 
and oleic acid (1.14 g) were dissolved in 1-ocatadecene (40 g (at room 
temperature)). This mixture was then heated to reflux, at 320
o
C, at a constant 
3
o
C/min at which the solution turned from red to brown to black as the 
temperature rose. Excess ethanol was then added to precipitate out the 
nanoparticles, which yielded a black oily product. Where further attempts to dry 
the product under reduced pressure were not successful. 
 
2.1.4 Synthesis of FeO@Au nanocomposites 
Using the pre-synthesised Fe3O4 nanoparticles, it was possible to use the citrate 
binding of the SPIONs as a reducing agent for HAuCl4 akin to the Turkevich 
synthesis, with some slight modifications. Firstly, HAuCl4 (20 mL) of varying 
concentration (0.1 - 5.0 mM) was heated to boiling and the previously synthesised 
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citrate-stabilised Fe3O4 (10 mL, 5 mgmL
-1
) was added instantaneously. With 
continued heating and mixing for 10 minutes, the solution turned from yellow to 
black to deep red/brown. The solution was then cooled to room temperature, 
washed with H2O and collected with a permanent magnet. The solution was then 
dried as before at -55
o
C and under reduced pressure producing red/brown powders 
(2-3 mgmL
-1
).  
 
2.1.5 Synthesis of gold nanoparticles  
Gold nanoparticles were synthesised via the Turkevich synthesis so as to be 
comparable to the iron oxide – gold nanocomposites. For this synthesis, a solution 
of trisodium citrate dihydrate (1.6 mL, 0.5%) was added to a solution of HAuCl4 
(20 mL, 0.18 mM) at 65 
o
C. Upon a colour change from yellow to red, the mixture 
was then boiled at 100 
o
C for 20 minutes.  
 
2.1.6 Particle size and morphology 
Particle size and morphology was performed using a combination of transmission 
electron microscopy (TEM), dynamic light scattering (DLS), and both UV-vis and 
infra-red (IR) spectroscopy. TEM was performed using a JEOL 1200EX MKII 
TEM microscope using an accelerating voltage of 120 kV. TEM samples were 
prepared by aqueous liquid drop of as-synthesised ferrofluid onto perforated 
carbon grids. DLS was performed on the aqueous ferrofluid with a Malvern 
Zetasizer Nano, using 1 mL samples in a 4.5 mL plastic cuvette. Ultra-violet 
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spectra were obtained on a Lambda 25 UV-Vis spectrometer from wavelengths 
300 – 1000 nm with a step size of 0.5 nm. The analyte was as-synthesised in an 
aqueous medium and recorded in a 4.5 mL cuvette. Infra-red spectroscopy was 
performed on a Perkin Elmer Spectrum 100 FTIR/ATR Spectrometer in the 
wavenumber range 600 – 4500 cm-1. 
 
2.1.7 Mössbauer spectroscopy 
The chemical composition was assessed using room temperature 
57
Fe Mössbauer 
spectroscopy, with the assistance from Dr Lara Bogart. Freeze dried samples were 
mixed with sucrose using a pestle and mortar and gently packed into a 22 mm 
diameter, ca. 2 mm thick disk-shaped sample holder. Transmission Mössbauer 
spectroscopy was performed at room temperature using a 
57
Co foil source 
embedded in a rhodium matrix with an initial activity of 25 mCi. The source was 
driven over a range of velocities from -15 mm/s to +15 mm/s via a SeeCo W302 
spectrometer using a constant-acceleration drive with triangular reference signal.  
Data were accumulated in a SeeCo W202 detector with 1024 channels (unfolded) 
that was calibrated against the Mössbauer spectrum of a standard α-Fe foil at 
room temperature. All spectra were fitted using the Recoil data analysis 
programme.[35] 
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2.1.8 X-ray spectroscopy 
X-ray photoelectron spectroscopy (XPS) was obtained with a K-Alpha X-ray 
Photoelectron Spectrometer system using monochromatic aluminium K-alpha X-
rays (0.83386nm, 1.4867 KeV). Energy-dispersive X-ray (EDX) spectra were 
obtained on a Philips XL30ESEM microscope. The crystal structure was 
investigated using powder X-ray diffraction (PXRD) which was achieved on a 
STOE STADI P transmission diffractometer using Mo Kα1 radiation (17.48 keV, 
λKα1 = 0.7093 Å) at 50 kV and 30 mA. The 2θ scan was performed between 
2.000
o
 and 50.015
o
 at steps of 0.495
o
 with a scan duration of 10 s/step. 
 
2.1.9 Magnetic heating 
The intrinsic loss parameters (ILPs) of the samples were measured using a 
Magnetic Alternating Current Hyperthermia (MACH) system built by Resonant 
Circuits Limited (London). This instrument comprised a purpose-built 6-turn 
copper solenoid operating at 967 kHz that produced a sinusoidally varying 
magnetic field of peak amplitude 6.6 kAm
-1
. Thermal heating curves were 
recorded as a function of time on application of the radio frequency (RF) field. 
Samples comprising 500 μL of fluid were placed into glass vials in the centre of 
the RF coil, and temperature variations were recorded by averaging the data from 
two Luxtron FOT fluoroptic probe thermometers (LumaSense Technologies, 
USA) immersed within the fluid. 
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2.3 RESULTS & DISCUSSION 
2.3.1 Synthesis 
2.3.1.1 Initial Reactions 
Initial reactions for the repeatability and suitability of the iron oxide synthesis 
were carried out, with all iron oxide nanoparticles being synthesised via the co-
precipitation method. This method has been widely studies, with this being a 
continuation of previous literature
[9]
 from the Parkin lab. Here ferric and ferrous 
chloride salts were dissolved and heated to 70
o
C and reduced with ammonia 
alongside a stabilising ligand; citric acid or tiopronin.  
 
 
Figure 2.1. Chemical structures of the stabilising ligands citric acid and tiopronin. Note 
that both molecules contain a carboxyl group, which is significant for the 
bidentate binding of the binding of the ligand to the iron oxide surface. 
 
These products were purified with water and isolated to black powders through 
freeze drying and from here classified as FeOx-tiopronin and FeOx-citrate 
respectively.  
Citric acid Tiopronin 
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Furthermore, it was through varying the reaction conditions, especially 
temperature, which yielded suitably repeatable nanoparticles. The synthetic 
temperature was varied from room temperature (25
o
C) through to 90
o
C.  
 
2.3.1.2 Citrate-capped iron oxide synthesis 
After repeated synthesis of both citrate-capped and tiopronin-capped iron oxide 
nanoparticles, FeOx-citrate was repeatedly synthesised in the aforementioned 
method before further functionalisation with gold. The iron oxide nanoparticles 
were added to varying concentrations of boiling chloroauric acid and heated until 
the colour change ceased. Again these products were purified with water and dried 
via freeze drying, at reduced pressure and -55
o
C, and classified as FeOx-Aux 
where x = Au concentration in mM. All products were then readily dispersible in 
water and formed strong ferrofluids.  
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Figure 2.2. (a) Photograph showing the citric acid stabilised ferrofluid FeOx-citrate with 
and without the influence of an external magnetic field. In the absence of the 
magnetic field the ferrofluid forms a stable suspension in water. (b) Graphic 
showing the morphology of the FeOx-Aux nanoclusters formed from 
hydrogen tetrachloroaurate reduction by citrate capped iron oxide 
nanoparticles. 
 
2.3.2 Structural characterisation of iron oxide nanoparticles 
2.3.2.1 Size and morphology 
Figure 2.2 shows the tunnelling electron microscopy of FeOx-citrate. The 
particles in the image can be seen to be roughly spherical in shape with the 
accompanying histogram showing a mean physical diameter of 8.0 nm with a 
standard deviation of 1.8 nm (147 particles).  
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Figure 2.3. (a) Transmission electron micrograph of the as-synthesised citrate-coated iron 
oxide nanoparticles and (b) the TEM-derived size distribution histogram for 
the inorganic cores. 
 
The particles appear to be synonymous with co-precipitation reaction schemes. 
There are characteristic size and shape particles, with some degree of 
polydispersity. There is also some aggregation of the nanoparticles when in 
solution. It also helps to show that each particle will, in all probability, possess 
only one magnetic domain which will occur when said particles are < 20 nm in 
diameter. 
The same can be seen in the dynamic light scattering (DLS) analysis performed 
on the FeOx-citrate nanoparticles. Firstly, the hydrodynamic diameter, φH, is 
given as 252 nm when measured by intensity and a polydispersity index (PDI) of 
0.27. The φH is considerably larger than the 8.0 nm seen via TEM analysis and 
can be attributed to the aggregation of the individual nanoparticles into larger 
clusters.  
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2.3.2.2 X-ray spectroscopy 
Powdered X-ray diffraction (PXRD) was used to identify the phases and 
crystallinity of the synthesised nanoparticles. This confirmed that FeOx-tiopronin 
and FeOx-citrate featured iron oxide in its cubic structure (Figure 2.4), showing 
the main characteristic peaks of (220), (311), (400), (511) and (440) at 13.76
o
, 
16.12
o
, 19.49
o
, 25.39
o
 and 27.73
o
 2θ respectively. As these peaks are synonymous 
with both Fe3O4 and γ-Fe2O3 it cannot confirm which state of state of iron oxide is 
present, especially in the nanoparticle state.
[144]
 
 
 
Figure 2.4. Mo-Kα θ-2θ powder diffraction pattern of FeOx-citrate nanoparticles, indexed 
against its cubic lattice miller indices. Note the high crystallinity due to the 
high signal to noise ratio. 
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High signal to noise ratio shows that the particulates are of a fine texture resulting 
in the clean and sharp diffraction pattern. From the Scherrer equation, the 
crystallite size was determined.
[145]
 This was calculated as 17 nm using the 
FWHM of the (311) plane at 16.1
o
 2θ. The PXRD spectra was achieved for both 
FeOx-citrate and FeOx-tiopronin, of which both had the same diffraction pattern. 
FeOx-citrate however was shown with lower intensity, suggesting a lower degree 
of crystallinity. This is reinforced by the Scherrer equation analysis showing a 
crystallite size of 9 nm.  
 
Figure 2.5. XPS scattering pattern of FeOx-citrate nanoparticles showing the presence 
and binding energies of Fe, O and C environments within the nanoparticles.  
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Preliminary X-ray photoelectron spectroscopy (XPS) data has been utilised to 
establish the elemental components and their environments within the 
nanoparticles.  
As seen in Figure 2.5 there are prominent scattering peaks for the carbon 1s 
electrons at 285 eV, oxygen 1s electrons at 530 eV and iron 2p electrons at 710 
eV. These are all expected to be present within the iron oxide nanoparticles. The 
Fe2p is exclusively from the nanoparticles, whereas the O1s electrons are present 
in both the nanoparticles and the stabilising ligands. Here FeOx-citrate is 
analysed, with the citrate ligands containing a high proportion of oxygen atoms. 
The citrate ligand also gives rise to the C1s electrons. This has then shown that the 
iron oxide nanoparticles including ligands, contains an atomic % of 15% iron 
from the Fe2p binding energy.  
 
2.3.2.3 Mössbauer spectroscopy 
Room temperature Mössbauer spectroscopy (Figure 2.6) of the FeOx-citrate as-
prepared material shows the distinguishing magnetic hyperfine splitting of the 
magnetite/maghemite series of iron oxides. This is shown as a distinctive six line 
absorption pattern. The best fit to the spectrum was obtained using Voigtian line 
profiles, following the quasi-phenomenological model recently described for 
fitting the Mössbauer spectra of Fe3O4/γ-Fe2O3 mixtures or solid solutions.
[146]
 
Voigtian line-shapes are used to represent a Gaussian distribution of hyperfine 
fields. The splitting of these fields can arise from physiological reasons, such as; a 
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range of morphologies, crystallographic impurities, or the presence of collective 
excitations.
[147]
 
 
 
Figure 2.6. Room temperature Mössbauer spectrum of the as-prepared citrate-coated iron 
oxide nanoparticles (FeOx-citrate) sample.  The best fit to the observed 
spectrum was obtained using two Voigtian sextets, each comprising two sub-
component spectra.  The residual between the observed data and the model is 
indicated by the lower trace 
 
The cumulative mean isomer shift or centre of gravity of the spectrum (i.e. the 
average over all the contributing subcomponent spectra) was determined to be 𝛿?̅?𝑇 
= 0.37 ± 0.01 mm/s, which lies between that of pure maghemite (𝛿?̅?𝑇 = 0.32 
mm/s) and pure magnetite (𝛿?̅?𝑇 = 0.53 mm/s). Given that it is more likely that the 
material is a mixture of phases than for it to be a solid solution – the latter being 
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more characteristic of bulk systems, while the former is known to be a 
characteristic of fine particle magnetite/maghemite systems
[147]
 – we can use the 
𝛿?̅?𝑇 measurement to estimate the composition of the mixture.  
Following an established procedure,
[147]
 𝛿?̅?𝑇 = 0.37 ± 0.01 mm/s equates to a 
magnetite content of 23% ± 5% w/w – meaning that 23 ± 5 wt.% of the as-
prepared iron oxide is in the form of magnetite, and the remaining 77 ± 5 wt.% is 
in the form of maghemite. 
 
2.3.3 Structural characterisation of iron oxide – gold nanocomposites 
Upon the addition of HAuCl4 into the synthetic procedure, there were significant 
changes detected in several aspects of the material. The post-production of iron 
oxide nanoparticles into iron oxide – gold nanocomposites was achieved through 
a Turkevich style gold reduction. Briefly, to boiling concentrations of HAuCl4 the 
as-synthesised citrate-coated iron oxide (FeOx-citrate) was added, where a colour 
change of black to burgundy was noted. This colour change was the first 
indication that a gold nanostructure had formed, with gold nanoparticles having a 
very distinctive and characteristic red colour. A series of gold-containing samples 
was synthesised, and from here-on will be classed as FeOx-Aux where x = 
[HAuCl4] used in synthesis. 
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2.3.3.1 Size and morphology 
Electron microscopy was used to study the morphological changes seen with the 
FeOx-Aux series of nanomaterials as a function of gold addition. TEM images 
seen in Figure 2.7 show these changes for a range of HAuCl4 concentrations and 
the corresponding histograms are in Figure 2.8. 
Most notably about the microscopy is that the size and shape of the iron oxide 
nanoparticles has remained largely unchanged. They appear as mostly spherical 
particles, with a diameter of 8-10 nm. This is as expected and can be used to show 
that the iron oxide is merely a carrier of the reducing agent in the form of citric 
acid. However, it can be clearly seen that the size of the Au nanoparticles shows 
consistent growth over the series. Larger and increasingly polydisperse collections 
of particles appear as the HAuCl4 concentration increases. Interestingly too, the 
iron oxide appears to be aggregating around the lager Au nanoparticles. 
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Figure 2.7. Representative TEM images of a selection of FeO-Aux iron oxide-gold 
nanocomposites, showing that the Au nanoparticles increase in size as the 
molar concentration increases, and that the iron oxide nanoparticles form 
aggregates surrounding the gold nanoparticles. 
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Figure 2.8. (a) Particle size distribution histograms derived from TEM data such as that 
shown in Figure 2.7 for a selection of FeOx-Aux iron oxide-gold 
nanocomposites. (b) Means and standard deviations of the iron oxide and (c) 
the gold particles as a function of the HAuCl4 concentration used during 
synthesis. Note that both the mean size and the polydispersity of the gold 
nanoparticles changes significantly over the series, while the iron oxide 
nanoparticles remain largely unaltered. 
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Furthermore, this can be confirmed with DLS data of the gold containing samples, 
which indicates that the particles were agglomerated in situ. Z-average 
hydrodynamic diameters, φH, of order 270 nm in FeOx-Au0.75 and 960 nm in 
FeOx-Au5.0, both with PDI’s of order 0.3. 
 
Figure 2.9. UV-vis spectra of FeOx-Aux samples with [Au] concentration  x = 0.25, 0.75 
and 1.0 mM, showing the red shift in the gold absorption peak as the Au 
concentration increased. 
 
UV absorption profiles of FeOx-Aux also supported this growth of Au 
nanoparticle size. As seen in Figure 2.9, the surface plasmon resonance (SPR) 
absorption band of gold increases in wavelength as the concentration of HAuCl4 
increases. Depending on the size of the nanoparticles the wavelength at which 
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gold absorbs radiation varies with larger particles red-shifting the wavelength. 
Gold typically absorbs light in the range of 520-550 nm. Absorption here occurs 
from 516 nm (0.25 mM), to 526 nm (0.75 mM), and 556 nm (1.0 mM) for varying 
[Au]. Gold nanoparticles, of diameter 4 nm are shown to have an absorption at 
aproximately λ = 520 nm[148,149] which is similar here to the smallest gold 
nanoparticles at 0.25 mM [HAuCl4]. As the gold nanoparticles subsequently 
increase in size, so too does the SPR band red-shift to longer wavelengths. 
 
2.3.3.2 X-ray spectroscopy 
PXRD was then obtained for FeOx-Aux particles, using the same parameters. As 
is shown in Figure 2.10a), the crystal structure of gold is present with the (111), 
(200), (220) and (311) planes at 17.36
o
, 20.02
o
, 28.48
o
 and 33.55
o
 2θ respectively. 
As well, there are the predominant peaks from the FeOx-citrate diffraction pattern 
therefore clarifying that the nanocomposites have been formed. There is a lower 
signal to noise ratio present compared to FeOx-citrate detailing that FeOx-Aux are 
coarser in morphology. Gold is known to grow unevenly when forming 
nanoparticles and coatings, which could cause this courser texture. PXRD also 
shows that there is no structural change between the different nanocomposites for 
either the (311) iron oxide peak or the (111) gold peak (Figure 2.10b) with both 
exhibiting the same diffraction peaks at different gold concentrations. 
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Figure 2.10. Mo-Kα θ-2θ powder diffraction patterns of FeOx-Aux nanocomposites 
showing (a) the FeOx and Au reflections in the FeOx-Au0.75 sample; and (b) 
the coincidence of the (311) iron oxide and (111) gold diffraction peak 
positions across the FeOx-Aux series. 
 
a) 
b) 
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XPS was then used to detect the presence and atomic % of gold within the FeOx-
Aux nanoparticles. Figure 2.11 shows the presence of gold in the nanocomposites 
with Au4f7 and Au4f5 having a binding energy of 84.3 and 88.1 eV respectively. 
This represented an atomic % of 1% gold. 
 
 
Figure 2.11: XPS of the Au specific binding energy region (between 80-90 eV) showing 
the presence of Au electrons showing the Lorentzian fitting for the Au 4f7 
and 4f5 orbital electrons. 
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A depth profile of the nanocomposite was then analysed to get some insight into 
the morphology (Figure 2.12). The depth profile showed there is little to no 
change in the form of the scattering of the gold peaks. Thus, this is indicative of 
the formation of iron oxide – gold nanoparticle clustering over iron oxide – gold 
core-shell nanospheres. This is depicted in the scheme which shows the possible 
formations of iron oxide – gold nanocomposites.  
 
 
Figure 2.12: XPS depth profile scattering of Au particles within the iron oxide - gold 
nanocomposite FeOx-Au0.75. Note that there is no loss off peak with each 
subsequent scan determining that gold is present throughout the whole 
sample.  
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2.3.3.3 Mössbauer spectroscopy 
57
Fe Mössbauer spectroscopy was recorded for the series of gold containing iron 
oxide nanomaterials, FeOx-Aux. This is shown in Figure 2.13, and it can be noted 
that the spectra vary considerably over the series. This is more clearly seen in 
Figure 2.13.b) which shows the difference spectra between the normalised FeOx-
citrate (x = 0) and each given [Au] concentration (x ≥ 0). At lower concentrations 
of gold and as the concentration increases from x = 0.1 – 0.75 mM, the spectra 
become broader in the central region, but the innermost lines still remain, whilst 
the outermost lines lose intensity. This is corresponding to a broad positive singlet 
peak superimposed over the original sextet at low [Au] (x ≤ 0.75 mM). 
In contrast, as the gold concentration increases further (x ≥ 1.0 mM) there is a 
recovery of the original (FeOx-citrate) sextet line shape, becoming a negative 
component with sharp peaks. The broad singlet that grew in the early samples, has 
all but disappeared when x = 5.0.  
As previous, for a more detailed analysis, fitting of the Mössbauer spectra was 
achieved with quasi-phenomenological model based on Voigt profiles (Figure 
2.14.a)).
[146]
 The same two sextet fittings were used as were used with the FeOx-
citrate spectrum (Figure 2.6) as well as a further sextet, and the other being best 
described as a broad quadrupole split doublet. The fitted parameters confirm the 
change in behaviour of the nanomaterial over the gold concentration range (x = 0 
to 5.0 mM). This is most notably in the area and splitting of the additional sextet 
component (Figure 2.14.b)) 
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Figure 2.13. (a) Mössbauer spectra measured at room temperature for increasing amounts 
of gold in the FeOx-Aux samples, from x = 0 (the iron oxide only sample, 
FeOx-citrate) to x = 5.0 mM. (b) Mössbauer ‘difference spectra’ obtained by 
subtracting the FeOx-citrate spectrum from the FeOx-Aux spectra. These 
spectra provide a model-independent visual indication of how the Au-
containing x > 0 spectra differ from that of the precursor FeOx. 
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Figure 2.14. (a) Representative fit to the Mössbauer spectrum of sample FeOx-Au0.75 
using a quasi-phenomenological model. The constrained subcomponents of 
the initial FeOx-citrate spectrum are shown in grey, with additional 
(‘extrinsic’) subcomponents highlighted in orange (sextet) and pink 
(doublet). (b) Variation of some of the fitted Mössbauer parameters as a 
function of the HAuCl4 concentration x: the percentage spectral areas of the 
extrinsic doublet and sextet components, and the mean hyperfine field (Hhf, 
in Tesla) of the extrinsic sextet component. 
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Although difficult to be decisive, there are several factors that could be attributed 
to this change in Mössbauer spectroscopy. It is clear to see that there has in fact 
been a change over the FeOx-Aux series, even from the lowest [Au] concentration 
sample FeOx-Au0.1. This could likely be due to the additional synthetic methods 
needed for the formation of the iron oxide – gold nanocomposite materials. 
Additional heating and processing is required for all samples, and this could be in 
an indication of further oxidation of iron oxide, from magnetite to maghemite, 
after primary synthesis. The mean isomer shift of the samples trended towards a 
slightly lower value of 𝛿?̅?𝑇 = 0.36 ± 0.01 mm/s across the series, which lends 
some weight to this hypothesis. This could also be showing a change in the 
properties of both iron oxide and gold at the interface between FeOx and Au 
phases. The presence of the doublet component is hence showing a less magnetic 
environment.  
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2.3.4 Magnetic hyperthermia 
The fundamental application for the iron oxide nanoparticles in this study was 
primarily hyperthermia generation. This was analysed by using a 6 turn RF 
(Resonant Frequency) coil [resonant circuits ltd]
[150]
 to determine the heating 
potential including both the specific absorption rate (SAR) and intrinsic loss 
power (ILP)
[90]
 of the iron oxide and the iron oxide – gold nanostructures. 
 
Figure 2.15. Photograph showing the 6-turn radio frequency induction coil that was used 
to generate the alternating magnetic field which caused heating via magnetic 
hyperthermia.  The sample sits inside the centre of the coil to give a uniform 
field strength, with an optical temperature probe located in the sample. 
[resonant circuits ltd]
[150]
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2.3.4.1 Iron oxide nanoparticles 
Of the two iron oxide nanoparticle samples, it has been shown in Figure 2.16 and 
Table 2.1 that the citric acid stabilised particles, FeOx-citrate, have more efficient 
heating. This is shown by both the temperature rise of 63.8
o
C and the calculated 
SAR and ILP values of 33.9 W/g and 0.81 nHm
2
kg
-1
 respectively. These values 
are comparative to other commercially available biologically stabilised super 
paramagnetic iron oxide nanoparticles (SPIONs)
[90]
. The tiopronin stabilised 
particles however, have ΔT = 20.8oC, a SAR of 7.7 W/g and an ILP of 0.18 
nHm
2
kg
-1
. For comparative reasons, both samples were made to a concentration 
of 50 mgml
-1
. 
The size and shape of the nanoparticles is partially responsible for this alteration 
in the temperature achieved. Fe3O4 nanoparticles with a single magnetic domain 
possess the highest potential magnetisation, however agglomeration can occur in 
which aggregates of multiple nanoparticles assemble. Thus, forming a cluster of 
particles with multiple domains which when aligned can result in ferromagnetic 
properties, where the particles retain magnetisation and are not exclusively 
paramagnetic. Therefore from this data, we can assume that citrate-stabilised 
Fe3O4 has a greater stability towards magnetic agglomeration. 
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Figure 2.16: Heating curve generated by FeOx-citrate and FeOx-tiopronin from exposure 
to an external alternating magnetic field in an aqueous solution. 
 
2.3.4.2 Iron oxide – gold nanocomposites 
Similarly, MACH analysis was performed on the FeOx-Aux samples. A similar 
method was employed where the as-synthesised iron oxide – gold nanoparticles 
were analysed within a 6 turn electromagnet at a fixed frequency of 964 kHz. 
Again heating was seen and to varying degrees for different Au concentrations. 
As shown, the highest temperature recorded was ΔT = 17.1oC for FeOx-Au0.75. 
Whereas, ΔT = 5.0oC for the weakest heating FeOx-Au0.25. Between these 
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maximum and minimum heating samples, ΔT = 13.3oC for FeOx-Au0.5, ΔT = 
11.2
o
C for FeOx-Au1.5 and ΔT = 9.2
o
C in the case of FeOx-Au3.0.  
Although these temperatures are much lower than the ΔT = 63.8oC seen for FeOx-
citrate nanoparticles, they are concentration dependent. The as-synthesised 
Fe@Au nanoparticles are of a much lower concentration, with as little as 5% of 
the concentration of FeOx-citrate. This also relates to the ILP and SAR values 
seen in Table 2.1. 
 
Figure 2.17: Heating curves generated from MACH analysis of FeOx-Aux nanoparticles. 
Where x = 0.25, 0.5, 0.75, 1.5 and 3.0 mM concentrations of Au. 
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Table 2.1. Table showing the comparative values for the concentration of gold (mM), iron 
oxide particle mass (mgml
-1
), specific absorption rate (SAR / Wg
-1
) and how 
this correlates to the intrinsic loss power (ILP / nHm
2
kg
-1
) 
Sample [Au] / mM 
Particle Mass / 
mgml
-1
 
SAR / Wg
-1 
ILP / nHm
2
kg
-1
 
FeOx-tiopronin 0 50 7.7 0.18 
FeOx-citrate 0 50 33.9 0.805 
FeOx-Au0.25 0.25 1.6 39.0 0.925 
FeOx-Au0.4 0.40 3.7 57.5 1.37 
FeOx-Au0.5 0.50 3.4 71.9 1.67 
FeOx-Au0.6 0.60 2.3 78.2 1.86 
FeOx-Au0.75 0.75 3.3 88.3 2.1 
FeOx-Au1.0 1.0 2.2 72.4 1.72 
FeOx-Au1.5 1.5 3.6 51.4 1.25 
FeOx-Au2.0 2.0 2.8 39.4 0.934 
FeOx-Au3.0 3.0 2.8 42.9 1.02 
FeOx-Au5.0 5.0 2.9 36.8 0.852 
 
This table can then be visualised as a graph (Figure 2.18) giving a clear 
comparison of the SAR and ILP values for the different nanocomposites. It shows 
how there is an ideal gold concentration of 0.75 mM for the synthesis of highly 
tuned magnetic gold nanoparticles. This has given rise to an IPL of 2.1 nHm
2
kg
-1
. 
Even at higher concentrations of gold the ILP is still greater than that of the 
magnetic precursor FeOx-citrate. Gold concentrations of 3.0 and 5.0 mM have 
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shown an increase up to 1.02 and 0.852 nHm
2
kg
-1
 respectively, compared to 
FeOx-citrate ILP of 0.805 nHm
2
kg
-1
.   
 
Figure 2.18. The corresponding intrinsic loss parameters across the series, illustrating a 
ca. 3x increase in heating capacity in the vicinity of x = 0.75 mM. 
 
These figures correspond well with other literature studies performed. For 
instance, Kandasamy et. al. have recently synthesised iron oxide nanoparticles 
coated with novel short chain surfactants amino-terephthalic acid (ATA) and 
terephthalic acid (TA) under co-precipitation conditions.
[151]
 These particles are 
shown to have a SAR in the range of 46.0 – 129.8 Wg-1 under specific 
frequencies. The range of coating of iron oxide nanoparticles in varying 
surfactants to make the particles more effective for magnetic hyperthermia is 
always growing.  
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Table 2.2: Table of particle mass, specific absorption rate (SAR) and intrinsic loss power 
(ILP) for the comparison of FeOx-citrate to the control samples of FeOx with 
sodium chloride or hydrochloric acid, FeOx-NaCl and FeOx-HCl respectively. 
Sample 
Particle Mass / 
mgml
-1
 
SAR / Wg
-1 
ILP / nHm
2
kg
-1
 
FeOx-citrate 50 33.9 0.805 
FeOx-NaCl 3.7 35.1 0.834 
FeOx-HCl 3.2 35.8 0.870 
 
Finally, to try and establish the effect the gold was having on the ILP, several 
control experiments were performed which were compared with FeOx-citrate and 
FeOx-Au0.75. It was established whether the ionic strength of the HAuCl4 was 
having an effect on the structural packing and ordering of the iron oxide particles. 
This was therefore achieved by substituting HAuCl4 with NaCl within the 
reaction. 
Secondly, the effect the pH had on the reaction mixture was studied. As HAuCl4 
is acidic, it was replaced with HCl of an equal concentration to determine if it was 
this acidic nature of HAuCl4 that increases the ILP values.  
From Table 2.2 it can be seen that the neither NaCl nor HAuCl4 had affected the 
heating potential of FeOx-citrate. As neither the sodium chloride nor the 
hydrochloric acid had an effect on the ILP values for FeOx-citrate then it 
determines that the addition of HAuCl4 is the sole cause for the improved 
hyperthermia. The addition of the gold has caused some morphological changes 
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which could reduce the amount of agglomeration and loss of superparamagnetism. 
However, more investigation is needed to determine the causes of these improved 
results. Guardia et. al. have also described the effects of Cl
-
 ions on the heating 
achieved via magnetic hyperthermia and the growth of dumbbell like Fe-Au 
particles.
[152]
  Stating that the Cl
-
 ions aid in the formation of dimers giving a 
record value of specific absorption rates (SARs) up to 1300 WgFe
-1
 at 330 kHz and 
24 kAm
-1
 was measured for dimers with an iron oxide domain of 24 nm in size, 
and concluding that the presence of gold possibly helped the heat dissipation to 
reach such remarkable values. However these particles were synthesised using a 
high temperature hydrothermal oleylamine synthesis in contrast to the co-  
precipitation used in this thesis. 
Likewise, different sizes of iron oxide nanoparticles have been analysed for 
magnetic hyperthermia.
[153,154]
 With debate still ongoing about the optimum size 
of an magnetic iron oxide core to be. 
This hydrothermal synthetic method was attempted multiple times throughout this 
research, where the iron salts were dissolved in an organic solvent, 1-octadecene, 
with oleic acid surfactant, and heated to high temperatures in excess of 320
o
C. A 
constant heating gradient was needed for the monodisperse nature of these 
particles, which was challenging with the high temperatures required. Literature 
reports a gradient of 3
o
C/min provides the most monodisperse particles. 
Furthermore, the organic nature of the nanoparticle surface caused unforeseen 
issues. Attempts to isolate the oleic acid-capped Fe3O4 precipitate with large 
amounts of ethanol did not succeed. As the ethanol was added, the polarity of the 
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solvent solution changes, which in theory should precipitate Fe3O4. However, the 
yielded product resembled thick black oil, in which there were still residue 
organic solvents that were unable to be removed via traditional evaporation under 
reduced pressure due to very high boiling point of 1-octadecene (315
o
C). It was 
concluded that these particles had formed as intended, as they were not a fine a 
black precipitate and nor did they appear to possess any paramagnetic properties 
when introduced to a permanent magnetic field. 
 
2.4 CONCLUSION 
In conclusion, it can be seen that a simple co-precipitation synthesis of iron salts 
can produce highly tuneable superparamagnetic iron oxide nanoparticles. The co-
precipitation of FeCl3 and FeCl2 with the addition of a stabilising ligand and a 
reducing agent has repeatedly synthesised SPIONs to a high quality. The particles 
have been shown to be roughly spherical in shape and composed of a mixture of 
Fe3O4 and Fe2O3 compositions as shown from TEM and XRD. This mixture of 
compositions is due to the readiness of Fe3O4 to oxidise in air.  
This report has shown that it is possible to change the capping ligands on the 
nanoparticles to a positive effect. As is seen where citric acid stabilisation was 
superior to tiopronin giving an ILP increase of 450% from 0.18 to 0.81 nHm
2
kg
-1
 
for tiopronin and citrate stabilised particles respectively. This has given insight 
into the continued ability to modify and tune an iron oxide core and how these 
steps can generate a meaningful contribution to oncology and nanomedicines. 
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With more research and development this could be a suitable alternative to harsh 
chemotherapies, radiotherapies and surgeries.  
Although there are obvious positives of a non-invasive thermal therapy of a 
multitude of cancers, this work can also highlight the issues with reproducibility 
and consistency of iron oxide nanoparticle synthesis. As shown in this data, 
tiopronin-capped iron oxides yielded a ILP of only 0.18 nHm
2
kg
-1
, which is 
significantly lower than that synthesised by Thomas et. al. which showed a 
heating ILP of 6.1 nHm
2
kg
-1
. Therefore, it is critical to establish well-known and 
reliable protocols if the use of iron oxide nanoparticles will ever become truly 
viable. 
This research has also demonstrated that it is possible to further improve the 
magnetic hyperthermia characteristics of citrate iron oxide nanoparticles by the 
addition of HAuCl4. The addition of the gold has altered the chemical structure 
and morphology of the iron oxide and hence increased the magnetic behaviour. 
TEM has shown that the gold has increased the size distribution of the iron oxide 
nanoparticles, theorising that some gold coating has been achieved. This has also 
been confirmed from UV spectrometry which shows a red shift for the gold 
coated iron oxide nanoparticles. The gold has also formed large particles to which 
have caused increased agglomeration of the iron oxide nanoparticles 
Finally, the gold has been seen to increase the magnetic hyperthermia potential of 
these particles. From using the citrate-stabilised nanoparticles as a core, the gold 
has over doubled the ILP values seen form 0.81 up to 2.1 nHm
2
kg
-1
. This is a 
highly positive outcome for these particles showing that gold has a positive effect 
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on hyperthermia, with a high degree of potential future applications, such as 
cancer therapy. It is yet to be fully understood why the addition of gold in a 
specific concentration has made such a vast change to the heat generation. 
Although, a possible hypothesis for this is that at x = 0.75 mM HAuCl4, the gold 
nanoparticles are formed in the most ideal spatial distribution to disrupt the 
overall localised magnetic field of the iron oxide aggregates. So that when the iron 
oxide particles cluster, each individual magnetic moment does not interact with as 
many nearby particles. It is believed here that x = 0.75 mM, is this optimum value 
where the gold structures are not too big nor too small, so that they disrupt this 
relationship between the individual iron oxide particles. 
The gold also exhibits strong surface plasmon resonance bands, seen in the UV 
spectrum, which is a key property of photodynamic therapy of cancer cells. 
Combined with hyperthermia, there is the potential to make a multimodal cancer 
therapy treatment. 
More applications are also possible for the iron oxide nanoparticles other than 
hyperthermia. There is current investigation into the use of these particles as MRI 
contrast agents (see Chapter 4) and in ultrasound probes, but only initial studies 
have currently been explored. With promising data, it will be a pathway to the 
development of a whole new category of possible medicines. 
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3 SURFACE ENHANCED RAMAN SCATTERING 
 
3.1 INTRODUCTION 
SERS spectroscopy is a powerful vibrational analysis leading to highly selective 
structural detection.
[155]
 Excitation of localised surface plasmon resonances 
enhances the electromagnetic fields and allows detection of very low 
concentrations of analyte. This amplification of vibrational signal from light 
occurs mainly in small nanoscale gaps, cracks, crevices and points of a plasmonic 
material. These so-called ‘hot spots’ are therefore desirable and typically occur in 
noble metals i.e. gold, silver, copper.
[156,157]
  
As such, gold nanoparticles have been widely explored as a highly selective 
sensing medium through the optically sensitive SPR bands. As detailed in Chapter 
1, this is useful for SERS detection of molecules and antibodies in biomedicine 
and security devices. The use of gold as a SERS substrate has developed greatly 
in recent years; changing from rough electrochemically etched materials with 
nanoscale gaps but poorly defined uniformity and reproducibility,
[158,159]
 to well 
defined uniform nanoparticles of many differing morphologies, such as spheres, 
rods and stars. For instance, Chaney et. al. show how highly structured and 
orientated silver nanorod arrays can produce a high sensitivity SERS substrate.
[160]
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Gold nanostars have been widely used recently as a possible highly sensitive and 
selective SERS probe with Khoury et. al. showing the difference in SERS 
enhancement factors for variable sized gold nanostars with an highest average 
enhancement of 5 x 10
3
 for 53 nm sized stars.
[161]
 
In this Chapter, an exploration into the developments and use of gold 
nanostructures is seen. Gold nanoparticles can be seen in a wide range of sizes, 
structures and designs. Gold nanospheres are the most common and simplest 
synthetically, being achieved via a citrate reduction to form mostly uniform 
monodisperse spheres. As well as spheres, gold nanostars are seen as desirable 
nanostructures for SERS spectroscopy. Most notably, they contain highly 
tailorable peak aspect ratios which contribute to the localised SPR bands and 
produce vast amplification due to high levels of ‘hot spots’ via 3-dimensional 
orientation and clustering. 
Furthermore, the development of iron oxide – gold nanocomposite materials, 
synthesised in Chapter 2, could prove of interest. With the ability to hold both 
magnetic properties and the optical localised SPR properties is of value. 
 
3.2 MATERIALS & METHODS 
3.2.1 Materials 
All chemicals and reagents were used as received and without further purification. 
For gold synthesis; chloroauric acid (HAuCl4), silver nitrate (AgNO3), citric acid 
(99%), and ascorbic acid were all purchased through Sigma Aldrich. For iron 
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oxide synthesis; iron(III) chloride hexahydrate (FeCl3.6H2O) (99%), iron(II) 
chloride tetrahydrate (FeCl2.4H2O) (98%), ammonium hydroxide (NH4OH) (25% 
in water w/w), citric acid (99%) and trisodium citrate dihydrate were all purchased 
through Sigma Aldrich. The dyes used for Raman analysis were crystal violet 
(CV) and malachite green isothiocyanate (MGITC), purchased through Sigma 
Aldrich. All water used was ultrapure and distilled to 18.0 MΩ.  
 
3.2.2 Synthesis of gold nanospheres 
Gold nanoparticles were synthesised as previously detailed via the Turkevich 
synthesis. As before, a solution of trisodium citrate dihydrate (1.6 mL, 0.5%) was 
added to a solution of HAuCl4 (20 mL, 0.18 mM) at 65 
o
C. Upon a colour change 
from yellow to red, the mixture was then boiled at 100 
o
C for 20 minutes. 
 
3.2.3 Synthesis of gold nanostars 
The synthesis of gold nanostars was achieved via the reduction of HAuCl4 with 
ascorbic acid and silver nitrate aiding the seed mediated growth of the vertexes. 
Briefly, HAuCl4 (400 μL, 10 mM) and AgNO3 (40 μL, 10 mM) were well 
dispersed in H2O (20 mL) and mixed for 2-3 minutes at room temperature; giving 
a molar ratio of Au/Ag = 10. To this an aqueous solution of ascorbic acid (80 μL, 
100 mM) was quickly added and mixed via agitation (avoid stirring) for 20 
seconds. A colour change from colourless to a red-blue hue occurred. The 
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nanostars were then collected via centrifugation (10000 rpm, 10 mins) and re-
dispersed in water.  
 
3.2.4 Synthesis of iron oxide – gold nanocomposites 
Synthesis of FeO–Au nanocomposite materials was achieved as previously stated 
(Chapter 2). Briefly, Fe3O4 nanoparticles were initially synthesised via a co-
precipitation method in which iron chloride salts, FeCl3.6H2O and FeCl2.4H2O, 
were dissolved in H2O in a 2:1 Fe
3+
:Fe
2+
 stoichiometric molar ratio. The orange 
solution was heated to 70 
o
C for 30 minutes in a N2 atmosphere where NH4OH (5 
mL, 28%) was added dropwise turning the solution black and heated for a further 
30 minutes. Citric acid (4 mL, 0.5 g/mL) was added and the temperature was 
raised to 90
o
C under reflux for 60 minutes.  
HAuCl4 (20 mL, 0.2 mM) was heated to boiling after which the citrate stabilised 
Fe3O4 (1 mL, 0.3 mgmL
-1
) was added instantaneously. With continued heating 
and mixing for 10 minutes and addition of excess citric acid (0.5 mL, 0.25 mg), 
the solution turned from pale yellow to red. The solution was then cooled to room 
temperature, washed with H2O and collected with a permanent magnet. 
 
3.2.5 Microscopy 
TEM images were obtained using a JEOL JEM-2100F TEM microscope using an 
accelerating voltage of 120 kV. TEM samples were prepared by aqueous liquid 
drop of as-synthesised nanoparticles onto perforated carbon grids. Ultraviolet 
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visible absorption spectra were obtained on a Hitachi U-2900 UV-Vis 
spectrophotometer from 300 – 1100 nm wavelengths with a step size of 0.5 nm. 
The analyte was as-synthesised in an aqueous medium and recorded in a 1.0 mL 
plastic cuvette. 
 
3.2.6 Surface enhanced Raman spectroscopy 
SERS was achieved using a Renishaw inVia™ Qontor® confocal Raman 
microscope from wavenumber 600 – 2000 cm-1 with a 633 nm and 785 nm laser 
using an extended grating scan type. Laser power was scalable from 10% - 0.1% 
depending on the levels of enhancement to reduce the possibility of saturation of 
the spectra.  
Samples preparation was done by mixing the nanoparticles (Au or FeO-Au) with a 
crystal violet (CV) or malachite green isothiocyanate (MGITC) dye in a given 
molar ratio. Ratios used were 9:1, 1:1, 1:9, Au:dye equating to 9, 5 or 1 μM 
solutions. This means that using CV and MGITC stock solutions prepared at 10 
μM and diluted to as low as 1 μM was achieved with the SERS active particles. 
Samples (20 μL) were dropped onto a slilica substrate and either scanned as 
solution or scanned after dried in a vacuum (0.4 bar) for 4 hours.  
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Figure 3.1. Chemical structures of the triarylmethane-based Raman sensitive dyes 
malachite green isothiocyanate (MGITC) and crystal violet (CV). 
 
3.3 RESULTS & DISCUSSION 
3.3.1 Synthesis 
Spherical gold nanoparticles were synthesised using the Turkevich method of the 
reduction of Au
3+
, in HAuCl4, with citric acid. Typically, HAuCl4 was brought to 
boiling where citric acid was then added. Citrate here acted as both a reducing 
agent and a stabilising ligand to form the monodisperse particles, leaving a ruby 
red solution.  
For gold nanostars (Au Stars) a synthetic procedure as described by Cheng et 
al.
[162]
 and further studied by Raghavan et al.
[163]
 was used. This seedless method 
to spiked gold nanoparticles was a facile one pot synthesis, in which a solution of 
HAuCl4 and silver nitrate (AgNO3) were mixed in a precise molar ratio of 10:1 
Au:Ag. Reduction of Au was achieved at room temperature with ascorbic acid. 
Malachite green isothiocyanate Crystal violet 
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The silver ions in solution act as nucleation points for the formation of the spikes. 
A colour change from colourless to blue is observed as the nanostars form. 
Iron oxide - gold nanocomposite materials were synthesised by the same route 
detailed in Chapter 2, with the iron oxide cores being formed via the co-
precipitation method. Excess citric acid was used as a stabilising ligand and as a 
reducing agent upon the post-synthetic addition of chloroauric acid. HAuCl4 was 
added at a concentration of [0.4 mM], giving rise to a red magnetic precipitate and 
colourless supernatant when collected on a permanent magnet. This goes some 
way to showing that the gold is bound to the magnetic iron oxide cores.  
Literature studies show the iterative hydroxylamine seeding to promote the 
reduction of Au
3+
 on the iron oxide surface to create a core-shell nanoparticle.
[50]
 
This synthetic method was attempted in this thesis, however the seeding was 
unsuccessful with little to no coating of gold achieved on the iron oxide surface as 
determined though absorption spectrometry. 
 
3.3.2 Microscopy 
For the high levels of enhancement required for SERS spectroscopy, a high 
degree of uniformity in the nanostructures is required. To assess the gold 
nanoparticles synthesised TEM images were collected. 
Gold nanospheres are shown in Figure 3.2.a), which shows highly dispersed 
uniform gold nanoparticles of a mean diameter of 4 nm and standard deviation, σ, 
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of 0.85 (measured over 113 particles). This is common for a citrate reduction 
synthesis and has been well documented in literature. 
Figure 3.2.b) shows the TEM images of gold nanostars. These nanoparticles are 
much larger than and less uniform that the spherical particles, with some particles 
reaching in excess of 200 nm from point to point. These nanostars are much more 
aggregated than the spherical nanoparticles, which can be attributed to the lack of 
stabilisation by ascorbic acid of the high surface charges. Furthermore, the gold 
nanostars have no functional polymer coating, which can be considered to 
improve the stability and dispersion of the particles. Noticeably, the points of the 
particles are sharp in nature, and not rounded. This is important for the localised 
surface plasmon resonance absorption profile of the particles and will be ideal for 
the surface enhanced Raman scattering spectroscopy.  
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Figure 3.2. TEM micrographs of a) spherical gold nanoparticles synthesised via the 
Turkevich method of Au
3+
 reduction by citric acid and b) spikey gold 
nanostars formed with silver nitrate (AgNO3) and ascorbic acid. 
 
The UV/Vis absorption spectra of the gold nanoparticles (Figure 3.3) shows this 
increased size of the nanostars structures. Firstly, it can be seen that the absorption 
peak for gold nanospheres is narrow and at the standard 540 nm. The gold 
nanostars however, have a red-shifted absorption with a broad spectrum which 
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peaks at 642 nm. This red shift is synonymous with growth of a gold nanoparticle, 
and this broad overall spectrum is seen because of several factors. Firstly, from 
the TEM images we can see there is a lack of uniformity in the particles size. 
Additionally, constructive overlap of the absorption profiles of the core of the 
particle and the spikes can contribute. The centre of a nanostar is representative of 
a nanosphere, thus absorbing in the 550 nm region, as with all colloidal gold 
nanospheres. This is combined with the higher 700 nm absorption of the longer 
aspect ratio spikes. Raghavan et al.
[163]
 however synthesised gold nanostars with 
high uniformity and polydispersity resulting in dual plasmonic bands.  
 
Figure 3.3. Spectra of the different morphologies of gold nanostructures, nanospheres and 
nanostars. Note that the Au stars have a much broader absorption profile due 
to the variation in size and star spike aspect ratio. 
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3.3.3 Surface enhanced Raman scattering 
3.3.3.1 Gold nanoparticles for SERS 
Surface enhanced Raman scattering spectroscopy was firstly carried out to see the 
degree of enhancement achievable from the gold nanostars particles. For this 
Figure 3.4 shows the comparison between the surface enhancement of crystal 
violet (CV) dye for the gold nanostars and nanospheres. In the same molar ratio of 
1 part gold, 1 part CV, relating to an overall concentration of CV of 5 μM, the 
spectra align exactly, with major peaks at 1170 cm
-1
, 1375 cm
-1
 and 1618 cm
-1
.  
 
 
Figure 3.4. SERS spectra contrasting the enhancement of crystal violet (CV) dye with 
spherical gold nanoparticles and spikey gold nanostars. 
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From these spectra gold nanostars are shown here to have a higher intensity and 
greater effect of SERS than the spherical gold particles. It can be theorised that the 
localised spatial proximity of each spike is in a more suitable position for surface 
enhancements.  The peak to peak intensities of this spectra are shown as 730, 
5600 and 7800 for CV, gold spheres and gold stars respectively.  
It is important to note that these solutions are assumed to be homogenous, 
therefore the concentration of gold nanostructures – CV will be constant. This 
means that the data is highly reproducible.  
 
 
Figure 3.5. Raman spectra comparing the SERS signal enhancement of crystal violet 
(CV) solution without gold nanoparticles and with Au nanostars in either a 
9:1 or 1:9 Au:CV molar ratio. Greatest enhancement was achieved using a 
9:1 ratio of Au stars. 
  
127 
Furthermore, Figure 3.5 shows the difference concentration and the molar ratio of 
the SERS substrate (here gold nanostars) has on the levels of enhancement 
achieved. The SERS effect was greatest when the molar ratio between gold 
nanostars and CV was at 9:1, (i.e. a 1.0 μM CV solution) giving a max intensity of 
22500 at 1620 cm
-1
. This is over a four-fold increase in SERS compared to Au 
stars in a 1:9 molar ratio with CV (9.0 μM CV solution). At the same wavenumber 
of 1620 cm
-1
, intensity = 5300. This can be attributed to both an increase in 
number of gold particles able to enhance the spectra, and a less saturated solution 
of CV. Also, compared to the intensity of 500 for pure CV, the gold nanostars can 
be stated to have a 50x peak to peak intensity enhancement.  
To determine if there is a noticeable effect when analysing SERS for a sample as 
a solution or dried on a substrate, gold nanostar solution was further compared to 
an equal amount of solution dried on a silica glass substrate under vacuum. Both 
materials greatly enhance the Raman signals of CV having a peak intensity of 
21200 at the Raman shift of 1618 cm
-1
.  
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Figure 3.6. Raman spectra showing SERS effect on crystal violet (CV) when gold 
nanostars (9:1 Au:CV) are in solution or dried onto a silica substrate. 
Enhancement peaks are comparable but 633 nm laser power for aqueous 
solution = 10%, and dry substrate = 0.1% 
 
Although both materials give comparable intensity in a 9:1 Au:CV ratio, it has to 
be noted that the laser power for each spectra is different. To avoid saturation of 
the spectrum, the dried nanostar substrate was obtained at a far reduced power of 
0.1%. However the same signal intensity was achieved for the solution based 
sample at 10%. This shows that the surface bound dried sample is a much more 
effective SERS analyte. Reasoning for this is due to the increased fluidity in a 
solution, resulting in a constant relocation of nanoparticles and a shifting of 
potential SERS active sites. Whereas, when dried to a silica surface the nanostars 
are locked into position. Homogeneity of the sample can also be affected by a 
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surface bound sample. Meaning there could likely be areas of the silica surface 
with a much greater concentration of both dye and SERS analyte giving rise to a 
pseudo-signal of higher than average intensity. 
This can be seen in Figure 3.7 where the issues with the homogeneity of the dried 
material can be seen. At given locations on the slide, there will be significant 
amounts of gold and CV giving a strong Raman enhancement. Whereas, due to 
the so called ‘coffee-ring’ effect, the distribution of the gold nanoparticles is not 
even across the slide.
[164]
 So although the spectra are of CV and have the same 
predominant peaks, they are all unfortunately at different enhancement levels. 
 
Figure 3.7 Raman spectra showing SERS effect on crystal violet (CV) when gold 
nanostars are dried on substrate. Note that the enhancement is different 
across all three substrates showing that reproducibility is a key issue. 
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3.3.3.2 Iron oxide - gold nanoparticles for SERS 
Using Au nanoparticles as a control, it can be seen that FeO-Au nanoparticles can 
enhance some of the same Raman peaks, but only on a silica substrate. The 
standard peaks for malachite green isothiocyanate (MGITC) enhancement are 
seen at 1176 cm
-1
, 1366 cm
-1
 and 1618 cm
-1
.
[165]
   
In solution there is very little intensity over the whole spectra. This can be 
attributed to the lack of localised gold concentration, i.e. the gold nanoparticles 
within the FeO-Au nanomaterial are too far apart (as seen in the TEM images of 
Chapter 2, Figure 2.7) that resonance ‘hot spots’ cannot be formed. 
The sharp peaks occurring in the FeO-Au do coincide with MGITC enhanced with 
Au spheres at some wavenumbers, such as at 1170 cm
-1
, 1380 cm
-1
 and the pair of 
peaks at 1600 cm
-1
. The intensity of these peaks is also much lower than those 
seen for Au spheres.  
Some of the peaks in FeO-Au on the substrate do not correspond to any of the 
MGITC peaks. Nor can they be attributed to the inherent Raman signal of Fe3O4 
which is present in the nanomaterial.
[166]
 The peak at 1000 cm
-1
, for instance, has 
high intensity and very sharp, which is accredited to the Si-O-Si asymmetric bond 
stretching vibration in the glass substrate.
[167]
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Figure 3.8. SERS spectra of malachite green isothiocyanate (MGITC) dye showing the 
enhancement of peaks using gold nanoparticle solution, and iron oxide – gold 
nanocomposite solution and substrate.  
 
3.4 CONCLUSION 
In conclusion, it has been shown that it is possible to synthesise gold containing 
nanoparticles of different morphologies in a facile manner for the use as surface 
enhanced Raman scattering spectroscopy probes. It can be shown that gold 
nanostars are a more effective SERS substrate than gold nanospheres due to the 
optimal spatial positions of the spikes. Au stars gave rise to a 1.4 fold increase in 
enhancement over Au spheres and a 50-fold peak-to-peak increase over pure 
crystal violet.  Furthermore, a 9:1 Au:CV molar ratio is seen to be most sensitive, 
showing a 4x enhancement over a solution containing a a 1:9 Au:CV molar ratio. 
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Finally, FeO-Au nanoparticles have been synthesised and exhibit a unique SERS 
spectra of MGICT, which still needs further development. Some of the 
characteristics of the SERS spectra are dissimilar between the FeO-Au and Au 
enhancement. It could be possible there is an artefact causing these peaks, as seen 
with the silica substrate, or more interesting perhaps the magnetic iron oxide cores 
are manipulating the gathering of SERS spectra.  
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4 MULTIMODAL IMAGING 
 
4.1 INTRODUCTION 
In this chapter the aim is to further investigate the adaptability of iron oxide 
nanoparticles. As discussed in Chapter 1, iron oxide nanoparticles have been a key 
material for MRI over the years and have seen wide development in multiple 
fields and technical applications, including biomedicine, due to the manipulation 
of its diverse properties and high intrinsic magnetisation. Likewise, more and 
more development into multi-modal imaging is occurring to collate as much data 
as possible from each probe material, and achieve a two-in-one imaging probe. 
For this we have shown the development of an iron oxide core nanoparticle being 
efficiently coated directly with a photoacoustic dye. Using well-known 
esterification chemistry we have been able to covalently bind carboxyl-
functionalised PA dyes onto the surface of the iron oxide nanoparticles. 
 With the increased potential for exploiting magnetic properties, iron oxide 
nanoparticles are therefore ideal material candidates for bio-optical probe 
development. Using different synthetic routes and surface modifications, 
nanoparticles can be tailored for very specific applications. The size and 
morphology can be manipulated to the preferential formation to deliver particular 
properties. This can be achieved through the various synthetic routes in which 
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iron oxide can be formed. The most common in literature being co-precipitation 
and hydrothermal syntheses.
[44,168,169]
 The former being used commonly as a facile 
mechanism for aqueous soluble nanoparticles. 
This also applies to the surface functionalisation of the particles; which can give 
improved aqueous stability, bio-distribution, and add or enhance intrinsic 
properties.
[18]
 Nanoparticles have to be stabilised in solution due to the high 
surface to body ratio and charged surface. This is typically achieved with neutral 
organic molecules and polymers, or inorganic and metallic shells.
[14,142,170,171]
 
Thus aiding the colloidal stability and reducing aggregation whilst improving the 
possibility for further functionalisation. Furthermore, surface functionalisation can 
add targeting moieties for even greater biological affinity and impact.
[172]
 Using a 
photoacoustic organic dye to fulfil this role is of particular interest as they have 
the potential to both stabilise the colloidal solution and impart novel 
characteristics through its natural absorption profile. Thus, iron oxide based 
nanoparticles can lead to an attractive multimodal imaging platform with many 
future possibilities. 
As MRI contrast agents, iron oxide nanoparticle materials have changed the way 
we look inside the human body due to its infinite penetration depth and high 
spatial resolution and contrast of soft tissues. As a non-radiative imaging 
technique, high strength magnetic fields are deployed to detect the relaxation of 
atomic nuclei. Contrast agents are employed in MRI to facilitate the modification 
of the relaxation times T1 and T2. Fe3O4 nanoparticles give a strong T2 contrast in 
which the signal intensity decreases in a T2-weighted image. FeOx nanoparticles 
can also be considered more biologically sustainable and less toxic than some 
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commonly used gadolinium based T1 contrast agents which increase the signal 
intensity on T1-weighted images.
[173]
 For example, literature reports show the r1 
and r2 contrasts of various iron oxide nanoparticles, each functionalised or 
synthesised by various routes and resulting in different values.
[119]
 With the 
highest r2 values seen in literature being within the order of >800 mM
-1
s
-1
 for 
Zn
2+
 doped magnetic nanoparticles.
[120]
 In very recent developments, ultra-small 
iron oxide nanoparticles have been seen to enhance the T1 contrast; making a Gd-
free positive contrast agent, with very little chance of iron overload in the 
body.
[121]
 
Multispectral Optoacoustic Tomography (MSOT) is another attractive bio-
imaging tool due to the ability to generate anatomical images with a deep 
penetration depth (5-6 cm) whilst keeping a high spatiotemporal resolution, all 
whilst being a non-radiative process. Typically; a short wave near-infrared (NIR) 
source pulses and irradiates the biological tissue and photoacoustic (PA) probe. 
The NIR pulse is absorbed, which generates a small temperature spike resulting in 
the generation of low scattering sound waves via thermoelastic expansion in the 
tissue medium and the probe molecule. Ultrasound transducers detect the 
incoming acoustic waves which can then be processed into ultrasound images. 
One beneficial property of an exogenous PA dye is the ability of spectral 
unmixing. Endogenous molecules such as oxy (HbO2) and deoxy-haemoglobin 
(Hb), melanin and water all exhibit a characteristic photoacoustic spectrum.
[174]
 
Because of this, literature studies typically use NIR photoacoustic (PA) dyes, with 
absorption in the region of 700 – 1000 nm. Most commonly used dyes are 
aromatic organic structures, such as indocyanine green (ICG), methylene blue, 
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thalocyanine, and chlorin e6 (C e6)
[104]
. With MSOT, it is then possible to track 
the dye and analyse specific cellular or molecular processes. MSOT imaging is 
therefore a useful tool for the imaging of tissue oxygenation and hypoxia, and 
blood vessel imaging for the likes of vascular disease or melanoma.
[175]
 
Henceforth, multimodal probe development for biological imaging is quickly 
becoming significant to facilitate the fast, effective and efficient gathering of the 
vast amounts of data necessary for quick, decisive medical diagnoses. This 
interest ultimately leads to multimodal probes with a combination of MSOT and 
MRI. The advantage of a dual modality MSOT-MRI probe is to provide the 
combination of detailed functional and molecular information from MSOT with 
the very high anatomical resolution given by MRI imaging. Combining the 
properties of multiple techniques gives the ability to analyse quickly and 
decisively by providing complementary information. Dual modality imaging 
techniques are common in bio-imaging; typically with MRI scanners often paired 
with positron emission tomography, in PET-MRI scanners to provide 
complementary information, with the use of nanoparticle-based probes.
[176]
 With 
new development of imaging probes, variations of multimodality can be achieved, 
as such, recent developments have shown the use of magnetofluorescent T2 MRI 
contrast agents for targeted MR and fluorescence imaging of neural stem cells.
[177]
 
With this desire to formulate a multimodal imaging probe based on iron oxide 
nanoparticles, in this manuscript we report on the synthesis and characterisation 
for novel photoacoustic functionalised iron oxide nanoparticles. Attachment of 
ICG and Flamma®774 dyes were achieved through activation and esterification 
between the magnetic particles cores and PA molecule; with the structural 
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characteristics of the iron oxide cores largely unchanged. This initial study reveals 
that Flamma®774 PA molecule attachment can achieve suitable MRI contrast 
agents that also produce a significant MSOT signal, under optimum conditions. 
 
4.2 MATERIALS & METHODS 
4.2.1 Materials 
Indocyanine green N-hydroxysulfosuccinimide sodium salt (ICG sulfo-NHS) and 
Flamma®774 N-hydroxysulfosuccinimide sodium salt (Flamma®774 sulfo-NHS) 
were supplied by BioActs (BioActs, Korea). 
Iron(III) chloride hexahydrate (FeCl3.6H2O), iron(II) chloride tetrahydrate 
(FeCl2.4H2O), ammonium hydroxide (NH4OH), citric acid, 2-(N-
morpholino)ethanesulfonic acid (MES) buffer, 1-[3-(dimethylamino)propyl]-3-
ethylcarbodiimide hydrochloride (EDC) , N-hydroxysulfosuccinimide sodium salt 
(Sulfo-NHS) and chlorin e6 trisodium (C e6) were all acquired from Sigma 
Aldrich. All reagents were used as receive without purification with ultra-pure 
double distilled water (18.2 MΩ) 
 
4.2.2 Synthesis of iron oxide nanoparticles 
The iron oxide nanoparticles were synthesized via a co-precipitation method 
previously used but with modifications
[168]
. This comprised of dissolving a 2:1 
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stoichiometric ratio of iron(III) : iron(II) in water and the addition of a strong base 
in an inert atmosphere. 
In a typical reaction, iron(III) chloride, FeCl3.6H2O (135 mg, 50 mM) and iron(II) 
chloride, FeCl2.4H2O (50 mg, 25 mM) were added to H2O (5 mL) degassed under 
the continuous flow of N2, forming an orange solution. The solution was heated at 
70
o
C for 30 minutes upon which ammonium hydroxide, NH4OH (28%, 5 mL) was 
added dropwise. The solution immediately formed a black precipitate which was 
then heated at 70
o
C for 30 minutes. Citric acid (4 mL, 0.5 gmL
-1
) was added as a 
stabilising ligand and heated at 90
o
C reflux for 1 hour. The black precipitate was 
then collected on a permanent magnet and washed with H2O (10 mL x3). The 
strong ferrofluid was dried under reduced pressure leaving a black powder. 
This reaction, although reproducible, produced nanoparticles that were not 
stabilised with a surfactant or a ligand. This results in a nanoparticle solution that 
readily undergoes aggregation to a point where the desired properties were no 
longer achievable. When the material aggregates, they become too large and 
heavy to be suspended in solution, therefore sonication of the material was used to 
re-disperse the colloidal suspension.  
 
4.2.3 Photoacoustic dye functionalisation of iron oxide 
For the attachment of photoacoustic (PA) ligands, shown in  
Figure 4.1, to the iron oxide nanoparticle cores, a modification of a previous 
technique for esterification was used. This focused on the attachment of three PA 
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dyes, chlorin e6, ICG, and Flamma®774. For easy of experimentation and in the 
interest of time, ICG and Flamma®774 were purchased having already been 
activated with the sulfo-NHS moiety.  
Initial reactions involved the attachment of C e6 onto the iron oxide core. This 
was trialled via multiple techniques. Firstly, a control experiment was carried out, 
to determine if any conjugation of the PA dyes would be achieved through the 
mixing of pre-synthesised iron oxide nanoparticles and the stock solution of dye 
chlorin e6. The dark green solution was mixed overnight, for 24 hours, and the 
resultant precipitate was collected on a permanent magnet. This extracted the 
black iron oxide cores out of solution, leaving the unattached green solution of the 
dye C e6. 
Further experiments involved in-situ coating of the nanoparticles, therefore, 
during nanoparticle fabrication, C e6 was added, to act as a stabilising ligand, in 
part of the commonly used citric acid that had been used previously.  
 
    
 
 
 
 
 
 
 
 
 
Chlorin e6 Indocyanine green 
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Figure 4.1. Chemical structure of activated photoacoustic dyes chlorin e6 and 
indocyanine green. Where the activated notation represents the Sulfo-NHS 
leaving group.  
 
4.2.4 Activation of photoacoustic dyes  
Ultimately, the reaction of C e6 and the iron oxide core was achieved by using a 
sulfo-NHS leaving group to activate the dye making esterification possible 
therefore, using a modified synthesis that has been previously reported on, 
activation of the dye was carried out. To achieve the catalysed reaction C e6 (1 
mM, 663 μg), as a green powder, was dissolved in MES buffer (aq) (pH 4.0, 30 
mL, 50mM). To this green solution, EDC (0.1 M) and sulfo-NHS (5.3 mM) were 
added and stirred at room temperature for 10 mins. This activated the C e6 
molecules and addition of FeOx NP’s (1 mL, 30mg/ml) whilst mixing overnight 
lead to conjugation of the dye to the nanoparticles and magnetic separation 
resulted in a dark green ferrofluid. 
Furthermore, the addition of ICG and Flamma®774 was achieved via the same 
synthetic route as C e6, however, the PA dye needed no activation and was used 
as purchased [BioActs, Korea].  
In this reaction, a NHS-activated photoacoustic derivative (ICG sulfo-NHS (10 
mM) or Flamma®774 sulfo-NHS (10 mM)), was added to a solution of MES 
buffer ( pH 6.5, 50 mM, 15 mL) giving a pale green solution. Addition of the as-
synthesised iron oxide nanoparticles (1 mL, before citrate stabilisation), and 
mixing overnight at room temperature formed the conjugated nanoparticles and a 
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dark green solution. The nanoparticle product was collected on a permanent 
magnet and washed with H2O (10 mL x3). The resultant magnetic precipitate was 
collected on a permanent magnet and of a dark green colour.  
 
4.2.5 Particle size and morphology 
Particle size and morphology was performed using a combination of transmission 
electron microscopy (TEM), dynamic light scattering (DLS), and UV-vis 
spectroscopy. TEM was performed using a JEOL JEM-2100F TEM microscope 
using an accelerating voltage of 120 kV. TEM samples were prepared by aqueous 
liquid drop of as-synthesised ferrofluid probe onto perforated carbon grids. DLS 
was performed on the aqueous ferrofluid with a Malvern Zetasizer Nano, using 1 
mL samples in a 4.5 mL plastic cuvette. Ultraviolet visible absorption spectra 
were obtained on a Hitachi U-2900 UV-Vis spectrophotometer from 300 – 1100 
nm wavelengths with a step size of 0.5 nm. The analyte was as-synthesised in an 
aqueous medium and recorded in a 1.0 mL plastic cuvette. 
 
4.2.6 Animal model 
All procedures performed in this study involving animals were in accordance with 
the ethical standards of the Institutional Animal Care and Use Committee 
(A*STAR Biological Resource Centre, Singapore, IACUC #151085/140898). The 
animals used (8-10 weeks-old females, 20-25 g) were NRC nude mice (U87 mg 
xenograft) from InVivos (Singapore). 8 – 10 weeks old NcR nude female mice 
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weighing between 20-25 g were used for this study. 200 ul of  5 x 10
6
 U87MG 
cells  (ATCC) mixed with matrigel in 1:1 volume was inoculated on the right 
flank of the mouse and imaging procedures were performed 3 weeks later. 
 
4.2.7 Multispectral optoacoustic tomography 
Multispectral optoacoustic tomography (MSOT) was performed on an iThera 
Medical MSOT inVision 512-echo small animal imaging system
[178]
. Assisted by 
Dr Amalina Attia and Dr Ghayatri Balasundaram, phantom samples were 180 μL 
and were prepared in a 10 cm cylindrical polyurethane phantom fabricated to 
simulate the characteristics and optical properties of mice and submerged in a 
water bath to aid with acoustic detection. Detection wavelength was in the range 
of 680 nm – 980 nm at 5 nm intervals across a length of 5 mm of the phantom at 
0.5 mm slices. 
Briefly, a tuneable optical parametric oscillator (OPO) pumped by an Nd:YAG 
laser provides excitation pulses with a duration of 9 ns at a repetition rate of 10 Hz 
with a wavelength tuning speed of 10 ms and a peak pulse energy of 100 mJ at 
730 nm. Ten arms of a fibre bundle provide even illumination of a ring-shaped 
light strip of approx. 8 mm width. PA signals were acquired using a 512-element 
concave transducer array spanning a circular arc of 270°. During MSOT 
measurements, the phantom is translated through the transducer array along its 
axis to acquire the transverse image slices set. 
For in vivo imaging, FeOx-774 (100 mM w/Fe in 5 μL saline) was administered 
through an intratumoral injection. Ultrasound gel was applied on the mouse skin 
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surface and measurements were recorded in 34°C water for good acoustic 
coupling. An animal holder with a thin polyethylene membrane was used to 
prevent direct contact between the mouse and the water. A volumetric region of 
interest (ROI) consisting of multiple transverse slices with an inter-slice distance 
of 0.5 mm. Ten frames were acquired and averaged for each wavelength (680, 
700, 760, 770, 780 (FeOx-774 absorption peak), 790, 800 (isobestic point of Hb 
and HbO2), 850, 900 nm). MSOT imaging was performed pre-injection, and 15 
minutes post-injection. 
 
4.2.8 Image reconstruction and processing 
MSOT images were reconstructed using a model-linear algorithm via ViewMSOT 
proprietary software. Thereafter, spectral unmixing was performed to resolve 
individual components from different chromophores in the system. For each pixel 
in the image, the method fits the total measured optoacoustic spectrum to the 
known absorption spectra of the individual chromophores, based on least-squares 
linear regression. 
 
4.2.9 Magnetic resonance imaging 
MRI relaxivity of the nanoparticles were evaluated by using a 7-Tesla Bruker 
Clinscan MRI system with the assistance of Michael Ng, Francesca Mandino and 
Dr Joanes Grandjean from the Singapore bio-imaging consortium, A*STAR. T2-
weighted relaxation times were determined from a multiecho spin-echo sequence 
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(repetition time (TR): 4000 ms; TE: 17.9–250.6 ms). r2 relaxivities were obtained 
from the slope of 1/T2 versus molar [Fe] concentration plots. Phantoms were 
prepared in 500 μL samples in a 1 mL plastic syringe, placed inside the coil. 
Animals were anesthetised using Isoflurane. Briefly, anesthesia was induced with 
4% isoflurane; animals were then positioned on a MRI-compatible cradle. 
Isoflurane was lowered to 1.5% for the whole MRI-scanning session.  Animal 
temperature was maintained at 37 ͦ C. Data were acquired on an 11.75 T Biospec 
(Bruker BioSpin MRI, Ettlingen, Germany) equipped with a BGA-S gradient 
system, a linear volume resonator coil for transmission and a 10 mm multi-
purpose surface receiver coil positioned over the tumour. Images were acquired 
using Paravision 6.0.1 software. Gradient-Echo MRI images were acquired using 
a fast low angle shot (FLASH) sequence: field of view (FOV) = 20 × 20 mm², 
number of slices = 20, slice thickness = 0.4, slice gap = 0.3 mm, MD = 192 x 192, 
TR = 15 ms, TE = 3 ms, flip angle = 50°, volumes = 1, bandwidth = 250 kHz. 
Two FLASH images were acquired: one before the contrast agent injection, as 
baseline, and one 5’ after the injection. 
 
4.3 RESULTS & DISCUSSION 
4.3.1 Synthesis 
All iron oxide nanoparticles were synthesised via the co-precipitation method, in 
which iron(II) and iron(III) salts were dissolved aqueously, heated and reduced 
with a strong ammonium hydroxide base. The citrate stabilised nanoparticles are 
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hereon referred to a FeOx-citrate. Further functionalisation of the particles was 
achieved through the novel covalent attachment of the photoacoustic dyes. The 
surface attachment between the iron oxide particles and sulfo-NHS activated dyes 
was a modification of a synthesis reported by Gil-Tomas et. al.
[179]
 The activation 
of the dye allows facile attachment of the molecule to the Fe-OH surface of the 
FeOx nanoparticles (Figure 4.2) via a common NHS esterification mechanism.
[180]
 
 
 
Figure 4.2. Reaction scheme of the photoacoustic molecule attachment to iron oxide 
nanoparticle surface, where PA represents the photoacoustic dyes Chlorin e6, 
indocyanine green or Flamma
®
774 
 
The first dye attached was Chlorin e6 (C e6). The sodium salt of the molecule 
provided a facile base for activation. The carboxyl end groups made esterification 
a possibility with the hydroxyl surface of the iron oxide via a condensation 
reaction. This process was then catalyzed, as shown by Figure 4.3 by EDC in the 
presence of sulfo-NHS.  
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Figure 4.3. Reaction scheme for the activation of chlorin e6 trisodium salt using 1-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC) and N-
hydroxysulfosuccinimide (Sulfo-NHS) in a 2-(N-morpholino)ethanesulfonic 
acid (MES) buffer solution.
[179] 
 
The other dyes include indocyanine green and Flamma
®
774, which were 
purchased with the Sulfo-NHS functional group pre-attached. These iron oxide 
core particles are therefore referred to as FeOx-ICG and FeOx-774 respectively. 
The final products were all dispersible in water and formed strong magnetic 
ferrofluids.  
4.3.2 Chlorin e6 functionalisation 
4.3.2.1 Characterisation of nanostructures 
To show the attachment of the PA dye was successful, UV was a critical tool for 
analysis. This allowed detailed optical absorption profiles for the newly formed 
particles and for us to assess if the dye had bound to the surface of the iron oxide 
  
148 
core.  Such is shown in Figure 4.4, where we see the absorption profiles of FeOx-
Ce6 and free unbound C e6. The absorption is strong for that of unbound C e6 
with a strong peak in the NIR range at 650 nm. Upon addition of the iron oxide 
core the peak remains, showing conjugation has been successful, although the 
signal is less intense and has red shifted to 680 nm.  
 
Figure 4.4. UV/Vis absorption spectra of chlorin e6 conjugated iron oxide and free un-
bound chlorin e6 showing the characteristic near IR peak in both samples. 
 
4.3.2.2 Multispectral optoacoustic spectroscopy 
As seen from the UV absorption, the nanoparticles do have a NIR absorption 
profile, therefore allowing for MSOT spectroscopy to be obtained. To confirm the 
enhanced conjugation when catalysed with Sulfo-NHS and EDC, a study was 
performed with both activated and non-activated C e6. Using a small amount of 
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aqueous sample in a phantom, Figure 4.5 shows the activated material has greater 
signal intensity. From this, we established that the activation has caused covalent 
binding through the condensation reaction mentioned beforehand. Whereas, when 
non-activated C e6 was reacted in the same conditions, we believe this signifies 
only physical absorption of the dye onto the surface has been achieved.  
This is also shown in the PA spectra that are obtained from the MSOT 
spectroscopy (Figure 4.6). Both the activated and non-activated C e6 compounds 
produce a PA signal, however the activated has approximately a two-fold intensity 
increase. This helps to confirm that catalysing the reaction with Sulfo-NHS to 
activate the carboxyl group on the chlorin e6 dye establishes a higher degree of 
coordination. 
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Figure 4.5. Multispectral optoacoustic image of chlorin e6 coated iron oxide (FeOx-Ce6) 
particles and the difference in photoacoustic signal intensity when synthesised 
with a) non-activated chlorin e6 trisodium and b) activated dye chlorin e6 
sulfo-NHS 
 
 
Non-Activated Activated 
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Figure 4.6. Photoacoustic spectra of the different synthetic routes to FeOx-Ce6 
production and the increase in MSOT intensity when using the activated 
chlorin e6 dye 
 
Due to the good PA intensity achieved from the iron oxide nanoparticles, it 
becomes important to check how spectral un-mixing could be possible with these 
probes. As previously detailed, spectral un-mixing is critical in MSOT 
spectroscopy. It is vital to be able to identify the exogenous probes from the 
endogenous contrast agents. For this we looked at multispectral analysis of 
Deoxy-Heamoglobin (Hb), Oxy-Heamoglobin (HbO2) and Iron Oxide Chlorin e6 
nanoparticles. The spectra in Figure 4.7 show that we can see the major PA peak 
of FeOx-Ce6 which occurs at 680 nm. This occurs at the lower limit of the near 
IR wavelength range for MSOT spectroscopy therefore when in-vivo analysis is 
performed there is a large similarity between the FeOx-Ce6 and Hb at these low 
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wavelengths. Furthermore, at higher wavelengths the FeOx-Ce6 signal will be 
masked by the HbO2 present. This makes the detection of the nanoparticles 
difficult in the current system.  
 
 
 
Figure 4.7. In-vivo MSOT spectrum for FeOx-Ce6 particles and endogenous contrast 
molecules oxy- and deoxy-haemoglobin (HbO2 and Hb) showing the 
absorption profile of FeOx-Ce6 is too similar to Hb for accurate spatial un-
mixing. 
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Figure 4.8. In-vivo MSOT image of a mouse flank showing there has been no 
accumulation of the iron oxide chlorin e6 imaging probe (FeOx-Ce6) resulting 
in poor signal intensity. 
 
Due to this difficulty un-mixing the spectra of FeOx-Ce6 from Hb, the in-vivo 
analysis of the mouse flank (Figure 4.8) showed very mixed signal intensity. It 
was unable to detect the nanoparticles sufficiently to be clinically useful. Another 
issue that needed to be overcome was absence of particle accumulation in the 
tumour site. The nanoparticles were injected intravenously through the tail vain 
and should be retained for a greater length in the tumour. As this accumulation 
cannot be seen it is most probable that the nanoparticles have aggregated in 
solution before administration. This resulting hydrodynamic radius of a cluster of 
nanoparticles is too great and becomes readily filtered and collected by the liver.  
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4.3.3 ICG and Flamma®774 functionalisation 
Due to the issues surrounding the spectral un-mixing of FeOx-Ce6, this section 
goes into the research involving the PA dyes indocyanine green (ICG) and 
Flamma
®
774. Both of these dyes are known for their PA properties with 
absorption and emission at a higher wavelength than chlorin e6 at approximately 
800 nm. 
 
4.3.3.1 Characterisation of nanostructures 
Electron microscopy shows the single core size and structure of the nanoparticle 
formations before and after dye conjugation. As seen in the TEM images and 
corresponding histograms (Figure 4.9), the citrate-capped nanoparticles, FeOx-
citrate, are of a spherical shape with a mean core diameter of 9 ± 3 nm with some 
polydispersity. The microscopy also shows that the synthesis of a FeOx-PA dye 
nanoparticle has little effect on the morphological behavior of the particles. ICG 
capped nanoparticles have a mean diameter of 8 ± 2 nm, whilst Flamma
®
774 
capped FeOx has a mean diameter of 9 ± 3 nm as shown by the histograms and in 
Table 4.1. This is common and comparable with previously synthesized 
nanoparticles formed via co-precipitation methods.
[168]
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Figure 4.9. TEM images of citrate-capped iron oxide nanoparticles, FeOx-citrate, and 
photoacoustic-capped iron oxide nanoparticles, FeOx-ICG and FeOx-774. 
Included are the respective histograms for the diameter of the particles, 
showing the similar sizes for the functionalised nanoparticles, spherical 
morphology and aggregation. 
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Table 4.1. Crystallite size and particles surface charge for the iron oxide and iron oxide – 
photoacoustic nanoparticles determined via TEM and DLS characterisation. 
Sample TEM / nm DLS / nm PDI Zeta potential / mV 
FeOx-citrate 9 ± 3 110 0.235 -21.4 
FeOx-774 8 ± 2 150 0.239 -24.0 
FeOx-ICG 9 ± 3 310 0.363 -16.9 
 
However, the TEM images show that there is aggregation of the nanoparticles 
when stabilised with both citrate and the PA dyes. This was confirmed with 
dynamic light scattering (DLS) showing in situ agglomeration with Z-average 
hydrodynamic diameter, φH, of 110 nm and polydispersity index (PDI) of 0.24 for 
FeOx-citrate (Table 4.1). DLS also showed that the PA dyes were less effective 
stabilizing ligands as the commonly used citrate capping agent. φH is in the order 
of 310 nm and 150 nm for FeOx-ICG and FeOx-774 respectively, with ICG being 
the least effective stabilising ligand and showing the most polydisperse of the 
particles, with PDI of 0.36. 
The clustering of the nanomaterials is random in nature and has no defined 
orientation.
[181]
 The main driving force in aggregation is the charged nature of the 
surface of the individual particles. All synthesized samples hold a negative zeta 
potential. FeOx-ICG has the weakest negative charge at -16.9 mV, which 
contributes to the greater aggregation seen. 
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Figure 4.10. UV-visible absorption spectra for probe particles FeOx-ICG and FeOx-774. 
Near IR absorption of the particles is shown at 830 nm for FeOx-ICG and 780 
nm for FeOx-774. 
 
Verification for the attachment of the PA dye onto the surface of the iron oxides 
can be seen in the UV-vis absorption spectra in Figure 4.10.  After thorough 
extraction of the iron oxide cores through magnetic extraction and washing with 
H2O, the absorption peak for ICG and Flamma
®
774 are both visible at 830 nm 
and 780 nm respectively. This is in accordance with the standard absorbance of 
unbound free ICG, at 800 nm, and Flamma
®
774, at 774 nm. This shows a redshift 
in the absorption of the dyes which is synonymous with the molecule being bound 
to the metallic particle core. 
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4.3.3.2 Multispectral optoacoustic tomography 
The attachment of a photoacoustic molecule to the surface of the iron oxide 
nanoparticles has allowed us to perform optoacoustic tomography to achieve a 
multimodal probe. The photoacoustic spectra and the subsequent images were all 
achieved using a polyurethane phantom model. The photoacoustic spectra (Figure 
4.11) were plotted in contrast with the endogenous contrast agents oxy (HbO2) 
and deoxy-hemoglobin (Hb). For an exogenous contrast agent to be visible, the 
photoacoustic spectra must not have interference from any of the internal 
biological contrasts. Figure 4.11 shows MSOT absorption spectra for Fe-ICG and 
FeOx-774 which are represented with peaks of 790 and 780 nm respectively. 
These wavelengths fall between the 755 nm peak of Hb and the rising absorbance 
of HbO2, thus making spectral unmixing of the probe possible against these 
endogenous contrasts. 
In contrast, the photoacoustic spectra of FeOx-citrate has low intensity and is not 
sufficient to un-mix the signals for the HbO2 spectra. Therefore, with the 
conjugation of the PA dyes, ICG or Flamma
®
774, however, the photoacoustic 
signal has been amplified making spectral un-mixing possible. 
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Figure 4.11. Photoacoustic absorption spectra for FeOx-ICG and FeOx-774 along with 
the contrast with the endogenous contrast agents oxy (HbO2) and deoxy-
hemoglobin (Hb).  The normalised MSOT absorption peaks at 780 nm for 
FeOx-774 and 790 nm for FeOx-ICG. Variation in the peak wavelengths 
absorbance makes spectral un-mixing possible. 
 
Multi-spectral processing of the photoacoustic absorption spectra over 
concentration shows the average MSOT signal acquired from FeOx-PA particles. 
The trend, shown in Figure 4.12, shows the signal obtained at increasing 
concentrations. As concentration increases, so too does the MSOT signal, 
reaching saturation at ~100 mM [FeOx]. The signal for both FeOx-ICG and 
FeOx-774 shows comparable intensity and the linear fit of the concentration curve 
shows similar absorption profiles. This demonstrates that FeOx-ICG and FeOx-
774 are both effective and suitable MSOT probes, even at low concentrations 
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<100 mM [FeOx]. However, the gradient of the linear fit is greater for the 
absorption of FeOx-774. Figure 4.12 shows a steeper gradient of 32x10
-3
 for 
FeOx-774 compared to 25x10
-3
 for FeOx-ICG. Thus allowing us to show that 
FeOx-774 is the better MSOT probe with higher PA efficiency. 
 
 
Figure 4.12. Concentration gradient with respect to multispectral optoacoustic (MSOT) 
intensity and linear fit for the MRI-MSOT probe nanoparticles FeOx-ICG 
and FeOx-774  
 
 
 
R
2
(ICG) = 0.9702 
R
2
(774) = 0.9942 
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4.3.3.3 Magnetic resonance imaging 
For a complete multimodal probe, the nanoparticles must also exhibit a contrast 
for MRI. For this a concentration gradient in a phantom study was achieved in a 
7-Tesla Bruker Clinscan MRI system. This shows the level of T2 relaxation 
caused from the iron oxide core from the equation: 
𝑀𝑥𝑦(𝑡) = 𝑀𝑥𝑦(0)𝑒
−𝑡/𝑇2 
   (4.1) 
Where, 𝑀𝑥𝑦(𝑡), is the nuclear spin magnetization vector and, t, is the time. This is 
easily extracted form an exponential fit of the relaxation curves. The scan was 
performed over increasing scan lengths from t1, 17.9 ms, to t14, 250.6 ms. 
Furthermore, the spin relaxivity; 
𝑅2 =  1 𝑇2
⁄  
   (4.2) 
which shows the degree to the T2-weighted contrast of the MRI image and a linear 
plot of R2 vs [Fe] (the concentration of the magnetic atoms) gives the relaxivity 
coefficient, r2, via the gradient.
[118]
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Figure 4.13. Plot of 1 𝑇2⁄  against [Fe] concentration and b) visual representation of the 
concentration dependent T2-weighted MRI contrast for FeOx-citrate, FeOx-
774, and FeOx-ICG. The positive linear trend gives the R2 relaxivity values 
for the nanoparticle materials. Included is the background of H2O to show 
the intensity of the contrast. 
R
2
(ICG) = 0.0052 
R
2
(774) = 0.9646 
R
2
(citrate) = 0.9431 
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From the gradient of the plots in Figure 4.13, the spin echo relaxivity, r2, is 
shown to be 230 mM
-1
s
-1
 for FeOx-citrate, 212 mM
-1
s
-1
 for FeOx-774 and only 
5.2 mM
-1
s
-1
 for FeOx-ICG. There has been little effect on the addition of 
Flamma
®
774 on the relaxivity of the nanoparticles. Whereas, ICG has shown a 
large decrease in R2, showing nearly negligible contrast in MRI, and a poor linear 
fit (R
2
 = 0.006). Even at higher concentrations of FeOx-ICG there is still no 
definitive MRI r2 relaxivity coefficient seen.  
Compare the r2 values to one industry standard and commercially viable iron 
oxide T2 contrast agent, Resovist, which has an r2 relaxivity coefficient of 151 
mM
-1
sec
-1
. 
One probable cause for this discrepancy with FeOx-ICG is thought to be due to 
the stabilisation and dispersion of the magnetic nanoparticle cores.
[182]
 As stated 
previously (Table 4.1), FeOx-ICG has a hydrodynamic radius of 311 nm, which is 
up to a three-fold increase in hydrodynamic diameter. FeOx-citrate and FeOx-774 
are shown to have φH of 108 nm and 146 nm respectively. For comparison, the 
hydrodynamic radius of Resovist is reported as 45 – 60 nm. This is a factor of two 
smaller than that of FeOx-citrate and FeOx-774 nanoparticles and a factor of 4 
smaller than Fe-ICG. Furthermore, indocyanine green is not a large stabilising 
molecule or high molecular weight organic polymer. Therefore the resultant φH is 
due to the aggregation of the negatively charged FeOx cores and not the ligand 
dispersion around the core. The TEM images (Figure 4.9) also shows that the 
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aggregation of the FeOx-ICG nanoparticles is greater. The images show much 
larger clusters of particles compared to those of FeOx-citrate and FeOx-774.  
This shows that aggregation of the particles can play a large role in the contrast of 
MRI agents. For a contrast agent to work, H2O molecules must be present as MRI 
measures the effect the exogenous contrast has on the proton spins of water. Well-
dispersed particles like those coated in citrate or the polymer-based iron oxide 
particles in the literature have a high contrast and relaxivity coefficient as there is 
a greater surface area of nanoparticle in contact with surrounding H2O. Therefore, 
development into the stabilisation and encapsulation of the photoacoustically 
active iron oxide through organic and bio-polymer chemistry is currently being 
investigated to further increase the dispersion coefficients and hopefully improve 
r2 values.  
 
4.3.3.4 In-vivo imaging 
To determine if the multimodality of the FeOx-PA nanoparticles is translatable to 
animal models and real world biological systems, in-vivo analysis was performed. 
This was achieved using the mouse model. Nanoparticle delivery was achieved 
with an intratumoral injection of the nanoparticle sample at 100mM FeOx 
concentration in a saline solution and scanned 15 minutes post injection. FeOx-
774 nanoparticles were analysed in-vivo as FeOx-774 provided both the highest 
photoacoustic signal output and the greatest MRI t2 contrast when compared to 
the FeOx-ICG nanoparticles. Due to the disparity between the relatively low 
concentration of Flamma
®
774 on the surface of the nanoparticles compared to the 
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FeOx in the core, the MRI was a much more sensitive imaging technique. This 
means that the concentration of nanoparticles needed for the MSOT was far 
higher than that for MRI. For this a 100 mM aqueous solution of FeOx-774 was 
injected once for both scans of MSOT and MRI producing high signal and high 
contrast images. 
MSOT images are shown in Figure 4.14 and show the pre-scan where there is 
some negligible background signal form the FeOx-774 wavelength. This is 
expected as the FeOx-774 spectra (see Figure 4.11) has multiple minor peaks 
which do partially overlap with the endogenous contrast agents Hb and HbO2. 
Upon intratumoral injection, spectral unmixing of the MSOT signal isolated the 
exogenous FeOx-774 optical contrast agent from the endogenous spectra. It can 
be seen that the signal intensity of the spectrally unmixed MSOT spectra is greatly 
increased at the tumour site on the right flank of the mouse due to the increased 
presence of FeOx-774 nanoparticles. The retention time for the nanoparticles in 
the tumour is high due to the method of introduction of the contrast agent. 
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Figure 4.14. Multispectral optoacoustic images of a mouse tumour model (tumour 
highlighted within the oval) showing the exogenous signal of FeOx-774 
(green) at a) the pre-scan of the tumour prior to injection and b) the 15 
minute post-injection scan after FeOx-774 intra-tumour injection showing 
the high photoacoustic signal localisation of the FeOx-774 nanoparticles in 
the tumour. For comparison, c) shows the endogenous contrast agents (Hb – 
blue, and HbO2 – red) 15 minutes post-injection of FeOx-774.  
 
 
Figure 4.15. Detailed images of a) Oxy- and deoxy-haemoglobin maps overlaid on 
ultrasound images of U87MG tumor (T indicated by white arrow) implanted 
subcutaneously in NcR nude mouse obtained before contrast agent 
administration and b) after injection of FeOx-774 nanoparticles. Where 
MAX represents total saturation of signal. 
a) b) c) 
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Figure 4.16. MRI images for a) pre-scan and b) 15 mins post injection showing the 
increase in t2 contrast within the tumour from the presence of FeOx-774 
nanoparticles. 
 
Following the MSOT scan the mouse model was transferred, without further 
injection, to acquire MRI images (Figure 4.16) and it shows that the addition of 
FeOx-774 nanoparticles leads to a strong t2 contrast with the pre-scan tumour 
(white region) becoming negatively contrasted upon addition of FeOx-774 
nanoparticles. This is expected due to the well-known nature of FeOx 
nanoparticles being a strong T2 contrast agent, and this demonstrates that the 
nanoparticles are still stable in the mouse model and do not aggregate and lose 
MRI contrast 
Many multi-modal FeOx imaging probes currently in literature use multi-step 
hydrothermal synthesis procedures of complex multi-phase structures held within 
polymer surfactants.
[183–187]
 Many of which are designed for MRI and, CT or PET 
imaging.  Hyaluronic acid coated of multi-core FeO-Au nanoparticles is one 
example by Li et. al.
[188]
  This nanoconstruct gives tri-modal imaging of MR-CT-
a) b) 
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PDT using a functionalised Fe via a 7 step synthetic method. This also gives good 
T2 contrast at 144 mM
-1
s
-1
.  
The particles presented in this thesis more closely resemble Janus/dumbbell style 
nanomaterials currently in literature. Reguera et. al. have shown how such shaped 
particles are suitable for all manner of imaging techniques including CT, MRI, PA 
and SERS.
[189]
 This synthesis can be seen a great advantage to nanoprobe 
development due its simplicity and high reproducibility.  
 
4.4 CONCLUSION 
This chapter therefore shows how we have created a facile way to make a 
multimodal MRI–MSOT nanoparticle probe using a novel surface attachment 
chemistry of a PA dye onto the surface of iron oxide nanoparticles. Initial 
synthesis of chlorin e6-coated iron oxide nanoparticles showed that the chemistry 
can successfully coordinate a PA dye onto the metallic surface through a 
condensation reaction.  
The subsequent nanoparticles we report on show an enhanced photoacoustic 
signal form the presence of the PA dye, ICG or Flamma
®
774, With FeOx-774 
showing the highest MSOT efficiency. The obtained photoacoustic spectra exhibit 
a clear peak in the Near-IR wavelength region of 790 and 780 nm for FeOx-ICG 
and FeOx-774 respectively. This makes spectral unmixing of FeOx-PA 
nanoparticles and the endogenous contrast Hb and HbO2 possible. 
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Furthermore, we have demonstrated that FeOx-774 displays good MRI r2 contrast 
of 212 mM
-1
s
-1
, which is similar to the citrate coated FeOx-citrate r2 relaxivity 
coefficient of 230 mM
-1
s
-1
. This shows that PA dye functionalisation has little to 
no effect on the MRI properties of FeOx nanoparticles. However, FeOx-ICG does 
show vastly reduced contrast, at 5 mM
-1
s
-1
.  This can be attributed to the surface 
stabilisation produced via ICG molecules. TEM and DLS analysis showed much 
greater aggregation and clustering compared to FeOx nanoparticles coated with 
citrate or Flamma
®
774 conjugation. Aggregation is important for imaging 
nanoparticles due to the mechanism of MRI because MRI uses a measure of the 
magnetic spin of protons in H2O. When the FeOx nanoparticles are large clusters 
there is less water present, resulting in few adjacent protons to enhance the 
contrast of the image and therefore a weak signal. 
In-vivo analysis also demonstrated how the nanoparticles can be used for spectral 
un-mixing of the nanoparticle absorption wavelengths and the endogenous 
contrast agents using MSOT. Furthermore, the nanoparticles showed high MRI 
contrast due to the good hydrodynamic dispersity and stability of the iron oxide 
cores. This also showed that FeOx-774 nanoparticles are stable in biological 
systems and the MRI or MSOT signals were not quenched. 
This can be seen as a critical development in the understanding of multimodal 
imaging probes, showing that there are facile methods for the synthesis of a 
feasible nano-probe combining both MRI and MSOT. Importunately, it is good to 
note that these particles are also of the same design of those in Chapter 2, where 
magnetic hyperthermia was investigated. In theory, these multimodal particles 
will also possess a hyperthermic response when under an external magnetic field. 
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This both open up the possibility for a multi-functional particle that can both 
image (with two modalities) and also treat the region of interest. 
Interestingly, with regards to the heating of the nanoparticles though magnetic 
hyperthermia, this will have an effect on the photoacoustic properties. As stated 
with the Grüneisen parameter, changes in local environmental factors, such as 
temperature, will affect the photoacoustic effect of the material. How the heating 
of the particles will modify the potential multimodal nature of these particles is 
yet to be investigated. 
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5 CONCLUSION 
5.1 CLOSING REMARKS 
In conclusion, this thesis has explored the synthetic methods and use of iron oxide 
nanoparticles in a wide range of applications; from magnetic hyperthermia 
therapy to multimodal sensing/imaging probes.  
Initial synthesis involved a co-precipitation technique for iron oxide nanoparticles, 
using the different stabilising ligands of citric acid or tiopronin. Highly spherical 
and monodisperse nanoparticles were produced but coalescence of the individual 
cores was troubling. The stabilising ligands were for the purpose of improving the 
colloidal stability of the particles and analysing their effect on the heating 
achieved through magnetic hyperthermia. Temperature profiles were gathered 
showing that citrate stabilised iron oxide nanoparticles were more effective at 
heating, furthermore, citrate-stabilising ligands can be advantageous towards 
further functionalisation. This further functionalisation came from the post-
production addition of gold onto the iron oxide surface through a modification of 
the Turkevich citrate boiling gold colloid synthesis. The main reason for this 
addition was two-fold; firstly gold may improve bio-stability and protect the iron 
oxide, while secondly, giving a superior anchor point for any polymer or peptide 
binding through thiol’s affinity towards gold. Unfortunately, but not 
unexpectedly, the gold addition did not evenly coat the iron oxide nanoparticles. 
Microscopy showed that gold nanoparticles were forming within the iron oxide 
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superstructure, and at different sizes dependant on the concentration of gold 
added. Interestingly, it developed that this was highly beneficial towards heat 
generation via magnetic hyperthermia resulting in almost a 3-fold increase in 
intrinsic loss power. As of yet the mechanism for this is still unsure, however 
there could be interference between the interfaces of the different phases. 
These iron oxide – gold nanocomposite materials were shown to have a 
combination of multiple beneficial physiological properties. The high levels of 
paramagnetism from the iron oxide and specific optical SPR bands from the small 
amounts of gold. Importantly after repeated synthesis and analysis of these 
materials it was determined that this synthetic method was widely reproducible. 
This is aided by the factor of a simple co-precipitation mechanism with few 
complex steps and mild reaction conditions. This is co-precipitation mechanism is 
advantageous over the other commonly used hydrothermal synthesis in most 
regards in my opinion. The only disadvantage being a relative lack of 
monodisperse nanoparticles for a co-precipitation reaction compared to the 
hydrothermal.  
Multi-modal imaging was therefore always a possible avenue to explore. Firstly, 
SERS spectroscopy was analysed to see if the nanocomposite gave strong Raman 
enhancement. FeOx-Au was therefore compared to gold nanospheres and gold 
nanostars. The gold nanoparticles were synthesised, in a similar method to the 
post-production of FeOx with Au, by the common Turkevich synthesis. Au stars 
were synthesised using a reduction method utilising silver nitrate as a seeding 
agent. Gold nanostructures have been well described to be ideal SERS substrates 
and these synthesised particles proved no difference. Gold nanostars proved to be 
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the most effective when dried to a silica substrate. Likewise the iron oxide – gold 
nanocomposite achieved SERS enhancement when dried under vacuum on a silica 
substrate, however not when in solution. This is attributed to the displacement and 
dispersity of any gold nanoparticles throughout the iron oxide, i.e. few gold 
nanoparticles are in close proximity to each other. This results in poor localised 
SPR bands throughout the whole solution. I think that this has the potential to be 
impactful within bio-imaging, due to the ability to actively recover the sensing 
medium. Using an external magnet, it would be possible to recycle and reuse any 
such Raman probe after suitable cleansing. This would make a magnetic SERS 
particle highly desirable in a scientific, economic and environmental aspect. 
Further multi-modality of iron oxide nanoparticles was achieved by pairing the 
magnetic cores with a photoacoustically active dye. Synthesis of this was carried 
out in a novel condensation esterification reaction between the FeOx cores and 
either C e6, ICG or Flamma®774 dyes. This synthetic route used bare 
nanoparticle cores and dyes possessing an activated carboxyl group. Activation 
was achieved with Sulfo-NHS in an MES buffer to lower the energy required to 
successfully covalently bind the dye to the surface Fe-OH of the nanoparticle. 
MSOT analysis of the new photoacoustic iron oxide nanoparticles showed that 
photoacoustic activity was present in all probes. Depending on the absorption 
profiles however, it showed that FeOx-Ce6 would not be visible in-vivo due to the 
similar PA profile of Hb. ICG and Flamma®774 both have more suitable 
absorption wavelengths between the peaks of Hb and HbO2 making them ideal 
conjugators.  
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To test the full abilities of this iron oxide – PA dye multi-modal probe, MRI was 
obtained and showed the high T2 contrast common with FeO nanoparticles. 
Interestingly, it was seen that FeO-ICG failed to have contrast even after being 
synthesised from the same iron oxide cores. This was attributed to the greater 
aggregation seen when the iron oxide nanoparticles were stabilised/coated with 
ICG. Therefore, it is clear to see that the ideal MRI-MSOT multi-modal probe 
synthesised here is that of FeO-774. The development of this multi-modal 
imaging probe is highly impactful due to the ability to gather data for two 
differing techniques with one nanoparticle solution.  
 
5.2 OUTLOOK 
The potential for magnetic hyperthermia as being one of the next processes in the 
fight against cancer, tumours and bacteria is still high. Tailoring magnetic 
nanoparticles to be efficient and powerful hyperthermia agents is important for the 
therapeutics and clinicians. This means that further research into more responsive 
and stable nanoparticles is necessary. For this, different ligands can be trialled in a 
comparative way to those of citric acid and tiopronin. These could include many 
biostable compounds and polymers such as dextran, oleic acid and etidronic acid. 
Furthermore, the iron oxide – gold nanocomposites are of great interest due to 
their improved hyperthermia characteristics and potential biocompatibility. This 
can lead to functionalization of the gold, resulting in selectively binding 
hyperthermia agents. In addition, biological studies will be carried out to 
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determine the overall effectiveness of these particles on cancerous cells and 
bacteria.  
However, it would be important to gather more analysis of the iron oxide – gold 
nanoparticles. SQUID (superconducting quantum interference device) is of great 
interest and will give detailed H plot analysis on the magnetisation of the 
particles, which could provide insight into the mechanisms surrounding the 
increase in ILP from gold addition.  
In this potentially very interesting SERS research, the outlook is towards further 
refinement of the nanoparticle analytes. As is shown, gold nanostars are an 
effective SERS agent however the synthesis still leaves much to be desired. The 
synthesis of highly controlled and repeatable gold nanostars is still seen as a 
challenge and that of key importance for the creation of a reliable and accurate 
SERS sensor. There are also other varied gold nanoparticle morphologies that 
could make useful SERS sensors. 
Furthermore, the synthesis of iron oxide – gold nanoparticles can be enhanced. 
The formation of a uniformly coated iron oxide core is of difficulty and requires 
more investigation. This has the potential to lead to the development of several 
easy to make multimodal sensing and imaging techniques, such as a magnetic 
resonance – photoacoustic – Raman (MR-PA-SERS) probe. It is also important to 
further investigate the spectra obtained from the iron oxide – gold nanocomposite 
material. The Raman spectrum contains many peaks not associated with the dye 
MGICT or the nanoparticles.  
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From the MRI-MSOT analysis we have determined that FeOx-774 is the best iron 
oxide core based MSOT-MRI probe that we have developed using a facile and 
simple chemical synthesis. However, this chemical synthesis can be easily altered 
with a variety of other suitable chromofluors making development of new 
magnetic PA probes possible. Together with further refinement of the 
nanoparticle structures which is still necessary, with stabilization and aggregation 
being key areas of development in the progression to make an ideal MSOT-MRI 
photoacoustic probe. Development into a specific targeting probe is of high 
interest and impact for clinical studies for where an intravenous administration of 
the contrast is more desired. 
It would also be of great interest to investigate the potential of combining the 
three techniques I have analysed these magnetic nanoparticles for. As the 
nanoparticles used for the bio-imaging were of the same characteristics and 
synthetic method of those used for thermotherapy, it would be possible to have a 
imaging probe combined with therapeutics. However the surface ligands of the 
iron oxide will have significant effects on the magnetic heating so this would need 
to be studied. Furthermore, the heat generated from the magnetic hyperthermia 
can have knock-on effects for the generation of photoacoustics as it is 
fundamentally a thermally induced phenomenon. 
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